Joint Functions of METT-10 and Dynein in the Caenorhabditis elegans Germ Line by Dorsett, Maia
Washington University in St. Louis
Washington University Open Scholarship
All Theses and Dissertations (ETDs)
1-1-2012
Joint Functions of METT-10 and Dynein in the
Caenorhabditis elegans Germ Line
Maia Dorsett
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/etd
This Dissertation is brought to you for free and open access by Washington University Open Scholarship. It has been accepted for inclusion in All
Theses and Dissertations (ETDs) by an authorized administrator of Washington University Open Scholarship. For more information, please contact
digital@wumail.wustl.edu.
Recommended Citation
Dorsett, Maia, "Joint Functions of METT-10 and Dynein in the Caenorhabditis elegans Germ Line" (2012). All Theses and
Dissertations (ETDs). 571.
https://openscholarship.wustl.edu/etd/571
WASHINGTON UNIVERSITY IN ST. LOUIS 
Division of Biology and Biomedical Sciences 
Molecular Genetics and Genomics 
 
 
Dissertation Examination Committee: 
Tim Schedl, Chair 
Douglas Chalker 
John Cooper 
James Havranek 
Michael Nonet 
James Skeath 
 
 
 
Joint Functions of METT-10 and Dynein in the   
Caenorhabditis elegans Germ Line 
by 
 
Maia Dorsett 
 
 
 
 
 
A dissertation presented to the 
Graduate School of Arts and Sciences 
of Washington University in  
partial fulfillment of the  
requirements for the degree 
of Doctor of Philosophy 
 
 
 
 
May 2012 
 
Saint Louis, Missouri 
 ii 
 
ABSTRACT OF THE DISSERTATION 
Joint Functions of METT-10 and Dynein in the Caenorhabditis elegans Germ Line 
by 
Maia Dorsett 
Doctor of Philosophy in Biology and Biomedical Sciences 
(Molecular Genetics and Genomics) 
Washington University in St. Louis, 2012 
Professor Tim Schedl, Chairperson 
 
During normal development as well as in diseased states such as cancer, 
extracellular  “niches” often provide cues to proximal cells and activate intracellular 
pathways.  Activation of such signaling pathways in turn instructs cellular 
proliferation and differentiation.  In the C.elegans gonad, GLP-1/Notch signaling 
instructs germ line stem cells to self renew through mitotic cell division.  As germ 
cells progressively move out of the niche, they differentiate by entering meiosis and 
eventually form gametes.  Using this model system, I uncovered a cooperative role 
for the METT-10 putative methyltransferase and the dynein motor complex in 
regulating the balance between germ cell proliferation and differentiation.  I 
demonstrate that Dynein Light Chain-1 (DLC-1), and its partner, Dynein Heavy 
Chain-1, inhibit the proliferative cell fate, in part through regulation of METT-10 
levels and nuclear accumulation. I further show that the methyltransferase domain of 
METT-10 is required for normal inhibition of germ cell proliferation, and that DLC-1 
 iii 
and METT-10 act antagonistically to activation of the GLP-1 Notch pathway, which 
plays conserved roles in stem cell fate specification. Moreover, I find that regulation 
of germ cell proliferative fate is only one of multiple joint functions of METT-10 and 
the dynein motor complex, and propose that they function together in multiple 
cellular contexts, including mitotic cell division. The finding that METT-10 and 
dynein inhibit germ cell proliferative fate, despite promoting mitotic cell division of 
those cells that do proliferate, highlights a genetic difference between the 
specification of proliferative fate and its execution. 
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Chapter 1 (Introduction):  
The C.elegans Germ Line as a Model for Stem Cell Biology 
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A recurring theme of development and disease is the proper specification of 
cell fates or lack thereof.  Of the many developmental decisions that fall under the 
umbrella of cell fate specification, the regulated balance between cell proliferation 
and differentiation plays a fundamental role in tissue development and maintenance.  
A specialized cell type, the stem cell, is the cornerstone of regulated proliferation and 
differentiation, for it has the unique ability to both self-renew through proliferation 
and to give rise to daughter cells that differentiate (Lin, 1997; Morrison et al., 1997).  
While it is these fundamental characteristics that make stem cells alike, the genetics 
and cell biology of stem cell fate and proliferation can differ according to organism, 
tissue, and developmental context.  A comprehensive understanding of the diversity 
of paradigms regulating stem cell fate, maintenance, and proliferation will enhance 
our fundamental views of what “stemness” entails, and its misregulation in disease 
states such as cancer. 
 
Current and contrasting models of stem cell self-renewal 
 Most models of stem cell self-renewal fall into three predominant paradigms: 
(1) asymmetric division, wherein one daughter cell is specified to remain a stem cell 
and the other daughter cell differentiates, (2) symmetric division in which the stem 
cell divides to give rise to two daughter stem cells or two daughter cells that will 
differentiate, and (3) population-level self-renewal wherein the collective behavior of 
cells provides a steady source of proliferating cells that can differentiate at some 
frequency (Lin, 1997).  These paradigms are not organism-specific or tissue-specific, 
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as multiple paradigms can operate within a single organism and in the same tissue-
type between organisms. 
 Two excellent examples of the asymmetric division paradigm come from 
studies in Drosophila, although this paradigm is also characterized in mammalian 
tissues, including neural and hematopoietic stem cells (Takano et al., 2004; 
Beckmann et al., 2007; Doe, 2008).  Asymmetric division, which leads to the 
formation of one stem cell and a daughter cell which differentiates, can be mediated 
by intrinsic and extrinsic factors (Figure 1).   
An example of the role of intrinsic factors in guiding asymmetric division 
comes from studies of the Drosophila neuroblast (NB), which divides asymmetrically 
to self-renew a NB and give rise to a Ganglion Mother Cell (GMC) that differentiates 
(reviewed in (Doe, 2008).  Proteins that are asymmetrically segregated between the 
future NB and GMC play a significant role in determining cell fates.  One example of 
such a protein is the pro-differentiation factor Numb.  Numb is segregated into the 
future GMC and functions as an inhibitor of Notch signaling which promotes the self-
renewal fate (Uemura et al., 1989; Guo et al., 1996; Lu et al., 1998; Ohshiro et al., 
2000). Factors that are segregated into the future NB include aPKC, which among 
other things, functions to inhibit proper localization of Numb (Smith et al., 2007). 
Extrinsic factors guiding stem cell self-renewal are often provided by the 
niche micro-environment (Walker et al., 2009). While such extrinsic factors are 
probably essential for the establishment and/or maintenance of all stem cells, the 
division of germ line stem cells (GSCs) in Drosophila provides a particularly elegant 
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example of how extrinsic factors can determine stem cell fate.  In the male, GSCs 
reside at the apical tip of the testes surrounding a somatic hub, and divide to self-
renew a GSC and to give rise to a gonialblast that will differentiate (Dansereau and 
Lasko, 2008).  To remain a GSC, a cell must remain in contact with the hub, which 
secretes the short range signaling molecule and JAK/STAT ligand Unpaired (Upd) 
(Yamashita et al., 2003; Dansereau and Lasko, 2008).  Activation of the JAK/STAT 
signaling pathway maintains GSC fate.  Because contact with the hub (which serves 
as the stem cell niche) is essential for maintenance of GSC fate, asymmetric division 
is achieved by orienting the mitotic spindle at a right angle to the GSC contact with 
the hub (Yamashita et al., 2003).  After cell division, one cell maintains hub contact 
and remains a GSC, while the other lacks hub contact and becomes a gonialblast. 
In contrast to the strictly asymmetric division observed for male Drosophila 
GSCs, mammalian spermatogonial stem cells (SSCs) are proposed to undergo 
symmetric cell division, although there is significant debate on this matter (Lin, 1997; 
Oatley and Brinster, 2008).  Under the symmetric model, SSCs exist in a niche that is 
primarily made up of Sertoli cells (Oatley and Brinster, 2008).   Undifferentiated type 
A spermatogonia (As cells) act as stem cells, and can divide to give rise to either 
additional two As cells that separate or to two Apr cells that remain as an 
interconnected pair and differentiate (Lin, 1997).   
The third paradigm, population-level self-renewal, is most clearly illustrated 
by C. elegans germ cell development (Lin, 1997).  The adult C. elegans 
hermaphrodite gonad exists as two U-shaped gonad arms that meet at a common 
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uterus (Figure 2).  Each gonad functions as an assembly line with distal to proximal 
polarity with respect to the uterus.  At the distal region near the somatic distal tip cell 
(DTC), extending approximately 18-20 cell diameters and encompassing 200-250 
cells, are the proliferating germ cells, including the germ line stem cells (Hubbard, 
2007).  Proliferation of this distal cell population provides a continuous flux of germ 
cells that pushes germ cells away from the distal niche and promotes their entry into 
meiosis.  At a staggered region called the “transition zone” corresponding to 
leptotene/zygotene of meiosis I, germ cells definitively enter meiosis as evidenced by 
expression of meiotic markers (Hansen et al., 2004a).  These germ cells then proceed 
through the stages of meiotic development to give rise to differentiated gametes or die 
by physiological apoptosis (Hubbard, 2007; Jaramillo-Lambert et al., 2007).  
Hermaphrodites first produce sperm at the 4th larval stage, and then switch to oocyte 
production in the adult, and a continuously mated hermaphrodite can lay as many as 
~1400 progeny in a lifetime (Kimble and Ward, 1988). 
On the gross morphological level, the renewal of C. elegans germ line stem 
cells resembles the renewal of male Drosophila GSCs, wherein the DTC takes the 
place of the Drosophila hub.  Similarly to the Drosophila hub, the DTC functions as a 
stem cell niche.  In fact, the DTC is necessary and sufficient for germ line 
proliferation and maintenance:  ectopic DTCs lead to additional proliferative zones 
(and ectopic germ lines) while early distal tip cell ablation leads to germ line loss 
(Kimble and White, 1981; Feng et al., 1999).  The DTC functions as a stem cell niche 
by expressing the membrane-bound Notch ligand LAG-2 and extends out cytoplasmic 
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processes that enable it to directly contact cells located 8-10 cell diameters away from 
the distal end (Kimble and Crittenden, 2007).  Binding of LAG-2 to the GLP-1/Notch 
receptor in the distal-most germ cells results in activation of the GLP-1/Notch 
signaling pathway in the germ cells and specification of proliferative fate.  Loss-of-
function mutations in the GLP-1 receptor cause premature meiotic entry of all germ 
cells, while GLP-1 hyperactivation causes germ cell overproliferation and germ line 
tumor formation (Austin and Kimble, 1987; Berry et al., 1997; Pepper et al., 2003).   
While C. elegans germ line development may resemble Drosophila GSC self-
renewal on the gross morphological level, there are significant differences.  First, 
there is no consistent spindle orientation among mitotically dividing C.elegans germ 
cells, and thus there is no evidence for regulated asymmetric division (Crittenden et 
al., 2006).  In addition, while the distal tip cell has processes that extend 
approximately 8-9 diameters away from the distal end, the proliferative zone extends 
anywhere from 19-26 cell diameters, suggesting that cells can proliferate in the 
absence of direct contact with the niche cell (Hansen et al., 2004a; Crittenden et al., 
2006).  Thus, it is thought that differentiation may be a consequence of a progressive 
displacement away from the niche (Morrison and Kimble, 2006), and the signaling 
pathways that enable such a transition are the object of intense research, including the 
thesis work presented here. 
On the surface, there are significant differences among the paradigms of stem 
cell self-renewal.  However, whether similar underlying mechanisms operate to 
ensure balanced stem cell self-renewal remains an open question.  Like many 
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biological examples, from developmental patterning to genome regulation, common 
molecular strategies can underlie seemingly disparate outcomes; often, such examples 
teach us what is most fundamental to the execution of a particular biological process.  
The apparent uniqueness of the C. elegans strategy for germ line maintenance thus 
makes it a prime candidate for expanding our understanding of stem cell self-renewal 
and the pathways that limit it.  
 
Genetic pathways underlying stem cell self-renewal and cancer 
 A genetic network ensures the switch from proliferative to meiotic fates in the 
C. elegans germ line (Figure 2; Hansen and Schedl, 2006; Kimble and Crittenden, 
2007).  As stated earlier, the primary signal instructing germ cells to proliferate is 
activation of the GLP-1/Notch signaling pathway in the germ cells themselves 
through interaction with the somatic distal tip cell expressing the Notch ligand, LAG-
2.  Binding of LAG-2 to GLP-1 receptor results in a series of cleavage events that 
release the intracellular portion of GLP-1.  GLP-1(INTRA) translocates to the nucleus 
where it complexes with LAG-3, and acts as a co-activator for the LAG-1 
transcription factor to promote the transcription of target genes that promote the 
proliferative fate (reviewed in Fiuza and Arias, 2007).  Most of these target genes 
remain unknown, although there is evidence that the PUF protein, FBF-2, is a 
transcriptional target of LAG-1 and functions to promote germ line stem cell 
proliferation and/or maintenance (Lamont et al., 2004).   
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There are two Notch receptors in the worm, lin-12 and glp-1. Although the 
proteins are functionally equivalent, lin-12 function is limited to the soma and 
embryo, and is best characterized in the vulva, while glp-1 functions in the germ line 
and embryo (Fitzgerald et al., 1993). Germ line proliferation is roughly proportional 
to the extent of GLP-1/Notch signaling.  Weak glp-1 gain-of-function mutations 
result in less penetrant and smaller tumors, while partial losses of glp-1 function 
result in smaller germ lines (P.M. Fox, unpublished data; Qiao et al., 1995; Kerins, 
2006).  Moreover, the finding that cells continue to proliferate for at least 10 cell 
diameters beyond the reaches of the distal tip cell means that Notch signaling persists 
outside of the DTC niche and is dampened with relatively standardized timing.  Thus, 
regulation of the strength and endurance of the glp-1 signal ensures a proper balance 
between germ line proliferation and differentiation. In many systems, the Notch 
molecule is regulated at the level of expression, surface availability, intracellular 
trafficking, and stability (Fortini, 2009; Fortini and Bilder, 2009).  In the C.elegans 
germ line specifically, several proteins have been propose to regulate Notch activity.  
These include a number of the sel (suppressor enhancer of lin-12) genes, most 
notably, sel-10, an E3-ubiquitin ligase that regulates Notch levels (Sundaram and 
Greenwald, 1993; Lai, 2002) and the proteasomal component, pas-5 (Macdonald et 
al., 2008).  
GLP-1 signaling inhibits at least three genetic pathways that promote meiotic 
entry and/or inhibit proliferation (Figure 2; Hansen et al., 2004a).  Two of these 
pathways are characterized by the genes gld-1 and gld-2; gld-1 encodes a K-
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homology RNA binding domain containing protein and functions as a translational 
repressor, while gld-2 encodes a poly-A polymerase and functions, in part, to promote 
GLD-1 levels (Jones and Schedl, 1995; Lee and Schedl, 2001; Wang et al., 2002; 
Hansen et al., 2004b).  gld-1 and gld-2 single mutants exhibit a significant amount of 
meiotic entry and various meiotic defects (Francis et al., 1995; Kadyk and Kimble, 
1998).  However, simultaneous disruption of gld-1 and gld-2 leads to the formation of 
large germ line tumors with minimal meiotic entry (Kadyk and Kimble, 1998; Hansen 
et al., 2004a).  Moreover, these tumors occur in the absence of glp-1 activity, 
demonstrating that one of the primary roles of glp-1 signaling is to inhibit the 
function of gld-1 and gld-2. The fact that some meiotic entry is observed in gld-1 gld-
2 double mutants demonstrates that at least one other pathway operates in parallel to 
gld-1 and gld-2 to promote meiotic entry (Hansen et al., 2004a). Several other genes, 
namely gld-3 and the PUF protein nos-3, also promote meiotic entry and inhibit 
proliferation downstream of glp-1.  These proteins, like gld-2, function in part to 
promote GLD-1 levels (Eckmann et al., 2004; Hansen et al., 2004b).  GLD-1, in turn, 
represses translation of a number of target genes, including glp-1 itself (Marin and 
Evans, 2003). 
 One of the key questions in stem cell biology is whether similar genetic 
mechanisms underlie the diversity of paradigms for stem cell self-renewal. Several 
lines of evidence suggest that homologous factors regulate stem cell fate and 
proliferation across paradigms.  These factors include the PUF (Pumilio and FBF) 
protein family of translational regulators, piwi proteins, and the Notch signaling 
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pathway (Wong et al., 2005).  The Notch signaling pathway plays a particularly 
pervasive role in stem cell regulation.  In addition to promoting C. elegans germ cell 
proliferative fate, Notch signaling promotes the adoption of the NB stem cell fate in 
Drosophila (Doe, 2008) and the maintenance of stem cell fate in several mammalian 
cell and tissue types, including melanoblasts, neuroblasts, hematopoietic precursors, 
and the intestine (Pinnix and Herlyn, 2007; Doe, 2008).  In most cases, Notch is 
activated in the stem cell itself, but the stem cell can also act as the ligand expressing 
signaling cell in order to promote its own maintenance.  For example, female 
Drosophila germ line stem cells express the Notch ligands Delta and Serrate and 
signal to the niche. One function of the signal is to maintain the population of niche 
cells, which in turn, maintains germ line stem cell fate (Dansereau and Lasko, 2008). 
 Notch plays two qualitatively different roles in promoting stem cell 
proliferation. Notch signaling specifies stem cell fate and promotes proliferation per 
se through regulation of cell cycle progression mechanisms.  Both these roles can be 
co-opted by a number of cancers.  One example of the role of Notch activation in 
cancer is the inception and growth of T-acute lymphoblastic leukemia (T-ALL) (Roy 
et al., 2007).  Activating mutations in Notch1 are found in 55-60% of all cases of T-
ALL.  Notch likely promotes T-cell proliferation through upregulation of c-myc and 
downregulation of p53.  In addition, Notch1 plays early roles in T-cell development 
and fate specification, and it is thought that its leukemiogenic activity is a distortion 
of its regular developmental functions.   
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On a broader scale, increasing evidence suggests that Notch activation may 
promote cancer through inappropriate specification of stem cell fate.  The “cancer 
stem cell hypothesis” proposes that many tumors are comprised of heterogenous 
population of cells that includes “cancer stem cells” – that is, cells that have the 
ability to self-renew and give rise to other cell types within the tumor (Visvader and 
Lindeman, 2008).  It is thought that cancer stem cells play key roles in tumor 
initiation, metastasis, and significantly, resistance to conventional treatments 
targeting only rapidly amplifying cell populations.  In some breast and brain cancers, 
it is proposed that aberrant Notch signaling promotes the self-renewal fate of cancer 
stem cells (Farnie and Clarke, 2007; Garzia et al., 2009; Korkaya and Wicha, 2009).   
Whether Notch activation affects cell fate or cell proliferation in a particular cancer is 
likely to be an important clinical consideration. 
 Finally, there are several situations where Notch acts to inhibit stem cell 
proliferation and self-renewal. For example, in mammalian skin, Notch1 acts as a 
tumor suppressor, as deletions lead to basal cell carcinoma (Roy et al., 2007), and 
Notch inhibits stem cell fate in the Drosophila midgut (Micchelli and Perrimon, 
2006).    
 
Stem cell self-renewal and cell proliferation 
Stem cell proliferation and self-renewal are separable though interrelated 
processes.  The term “proliferation” refers to cell division, while “self-renewal” refers 
to the specification of stem cell fate. In the asymmetric paradigm, where each division 
 12 
leads to the renewal of the stem cell and an addition of a cell that will differentiate, 
cell division is separable from cell fate specification, and there are genetic factors that 
have been shown to specifically affect one process or the other (Doe, 2008).  This is 
also true for symmetric cell division, where daughter cells must choose between 
“stem cell” and “differentiated” cell fates.    
The difference between proliferation and self-renewal is less clear when 
considering the paradigm of population level self-renewal in the C. elegans germ line, 
in part because what distinguishes the “stem-cell like” from “differentiated” cell 
populations is their method of cell division.  The distal proliferative zone is often 
referred to as the “mitotic zone” and the process of differentiation as the 
“mitosis/meiosis switch” (Kimble and Crittenden, 2007). Thus, the relationship 
between cell fate and cell division in the C. elegans germ line remains a relatively 
open question.   
One unanswered question is whether failures in one type of cell division or the 
other result in a fate change, or whether cell fates are specified prior to and 
independently of the ability of cells to execute mitosis or meiosis.  Some mutations 
(in the RNA regulators gld-1 and puf-8) that prevent the normal meiotic progression 
cause a return to mitosis (Francis et al., 1995; Subramaniam and Seydoux, 2003), 
suggesting that a failure in meiotic progression can lead to a reversal in cell fate, 
although it is unclear whether ectopically proliferating cells share the stem cell 
character of the distal population.  However, there are numerous mutations that 
disrupt meiosis, including early meiotic steps, that do not cause a return to mitosis, 
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suggesting that only specific progression defects can reverse cell fate (MacQueen and 
Villeneuve, 2001; MacQueen et al., 2002; Martinez-Perez and Villeneuve, 2005; Lee 
et al., 2007; Goodyer et al., 2008).  Furthermore, some genetic perturbations that 
cause mitotic cell cycle arrest do not cause bulk meiotic entry.  These include germ 
line RNAi of the Cdk1 homolog, ncc-1 (S. Arur, unpublished data) and mutations in 
glp-4 (Beanan and Strome, 1992).  However, it is possible that these factors are also 
required for meiosis as well.  Moreover, it is unknown if C.elegans germ cells can 
enter meiosis only at particular cell cycle stage, and how cell cycle progression may 
bear on competence for meiotic entry (Hubbard, 2007).   
Because the term “proliferation” has been used to refer to both cell division 
and fate choice in the C.elegans germ line, perhaps it is most appropriate to define 
“proliferative fate” as a decision to mitotically divide, and “proliferation per se” as 
the act of mitotic division.  Indeed, one of the main contributions of the thesis work 
presented here is to demonstrate that two factors required for a normal mitotic cell 
cycle, METT-10 and dynein, inhibit the specification of germ cell proliferative fate, 
demonstrating that proliferative fate is genetically separable from the act of mitotic 
cell division itself. 
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Figure 1.  Models of Asymmetric and Symmetric Stem Cell Division.  Cells that 
will adopt the “stem cell fate” are shown in green, cells that will differentiate are 
shown in red.  (A-B) Asymmetric division of stem cells is mediated by intrinsic and 
extrinsic factors. (A) In the Drosophila NB, the asymmetric localization of cell fate 
determinants relative to spindle orientation is essential for the adoption of differential 
cell fates. (B) Male germ line stem cells maintain their “stem cell fate” through 
contact with the somatic cell hub, which expresses the short-range signaling molecule 
Unpaired.  Asymmetric division is achieved by orienting the mitotic spindle 
perpendicular to cell contact with the hub, ensuring that only one cell maintains hub 
contact. (C) It is thought that mammalian male germ line stem cells undergo either 
symmetric division to either expand the stem cell population or to give rise to two 
(connected) cells that will differentiate. 
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Figure 2. Physical and genetic architecture of the proliferation versus meiotic 
entry decision in the C. elegans germ line.  The C.elegans adult hermaphrodite has 
two U-shaped gonad arms that meet at a common uterus.  Each arm is organized with 
a distal to proximal polarity.  At the distal region of the germ line, in contact with the 
somatic distal tip cell (1), are the proliferating germ cells (2).  Proliferation of these 
cells results in a net flux of germ cells away from the niche provided by the DTC, and 
meiotic entry at a region called the transition zone (3).  Germ cells that proceed 
through an extended meiotic prophase (4) to eventual give rise to sperm (5) at the L4 
larval stage and oocytes (6) in adulthood.  (A) Binding of the LAG-2 ligand 
(expressed by the DTC) to the GLP-1 Notch receptor in the distal-most germ cells 
activates the GLP-1/Notch signaling pathway and promotes the proliferative or stem 
cell fate.  One function of the GLP-1 signaling pathway is to repress the activity of 
genetic pathways that promote entry into meiosis and inhibits the proliferative fate 
(B). 
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INTRODUCTION 
 From early development to later life, tissues are formed and maintained by 
stem cell populations.  Stem cells have the unique ability to give rise to both 
differentiated cell types and self-renewing daughters, and must decide between 
maintaining self-renewing capability and differentiating.  A balance between cell 
proliferation and differentiation is critical for normal tissue development and the 
avoidance of disease. For instance, uncontrolled self-renewal is a hallmark of cancer 
(Krivtsov et al., 2006), while a failure to maintain proliferation is often equally 
detrimental (Kauffman et al., 2003). 
 The Caenorhabditis elegans germline offers an excellent model system to 
study factors regulating this balance.  C. elegans germ cells begin from germline 
precursors set aside early in life (Sulston et al., 1983).  Following initiation of post-
embryonic development, germline stem cells are specified to maintain a proliferative 
fate and undergo mitotic cell division, or to differentiate into gametes, whereby they 
enter a meiotic developmental program (Hansen and Schedl, 2006; Kimble and 
Crittenden, 2007).  This decision is spatially regulated within the gonad. Proliferating 
germ cells reside in the distal end and enter meiosis more proximally at a region of 
the germline called the "transition zone", which corresponds to leptotene/zygotene of 
meiosis I (Figure 1A).  Currently, there is no evidence for asymmetric division within 
the proliferative zone, and it is thought that differentiation may be the consequence of 
progressive displacement away from the niche (Morrison and Kimble, 2006).  
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  The signal for continued proliferation of germ cell precursors is provided by 
activation of the Notch signaling pathway in distal germ cells (Austin and Kimble, 
1987; Berry et al., 1997).  The ligand LAG-2, a member of the conserved family of 
Delta/Serrate proteins, is expressed by a somatic cell called the distal tip cell, 
effectively creating a "niche” (Henderson et al., 1994).  Binding of LAG-2 to GLP-1 
(one of two C. elegans Notch receptors) likely results in cleavage of the intracellular 
domain of GLP-1 and its subsequent translocation to the nucleus (Mumm and Kopan, 
2000).  Upon translocation to the nucleus, GLP-1 (INTRA) complexes with other 
proteins, such as the DNA-binding transcription factor LAG-1, to activate 
transcription of target genes which promote the proliferative fate (Lamont et al., 
2004; Wilson and Kovall, 2006).  This role of GLP-1 in promoting the choice of 
proliferative fate was elucidated primarily by genetic analysis. Loss of glp-1 function 
results in the premature differentiation and meiotic entry of all germ cells (Austin and 
Kimble, 1987), while constitutive activation of glp-1 causes germline tumors (Berry 
et al., 1997).  
 Although glp-1 signaling is a central component controlling the specification 
of germ cell proliferative fate, the mechanism of this important cellular decision is far 
from understood.  A complete picture of the components that transduce or inhibit the 
glp-1 signal, govern the maintenance of proliferative cells, and ensure their proper 
differentiation and entry into meiosis is essential for understanding cell fate decisions 
including aberrant cell fate decisions leading to human cancers (Weng et al., 2004; 
Koch and Radtke, 2007).  
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 To further characterize the specification of germ cell proliferative fate, we 
characterized a novel tumorous allele of the mett-10 gene isolated in a forward 
genetic screen for factors that disrupt the balance between germ cell proliferation and 
differentiation (Francis et al., 1995a).  We demonstrate that METT-10, a conserved 
putative methyltransferase, inhibits germ cell proliferative fate in C. elegans, possibly 
through inhibition of the pro-proliferative functions of the glp-1/Notch signaling 
pathway. 
 
 
RESULTS 
A mett-10 allele with a tumorous phenotype 
 To identify genes regulating the transition between proliferative and meiotic 
fates, we carried out a screen for recessive tumorous mutants exhibiting ectopic or 
excessive proliferation (Francis et al., 1995a).  We isolated an allele of mett-10, the 
worm ortholog of the METT10D putative methyltransferase of vertebrates (see 
below); mett-10(oz36) exhibits a cold-sensitive and partially penetrant tumorous 
phenotype (Table 1).  The tumorous phenotype is variable and includes both regions 
of ectopic proliferation near the “loop” region of the germline normally occupied by 
cells in meiotic pachytene, as well as what is typically called the “late-onset 
tumorous” phenotype, in which the distal proliferative zone progressively increases in 
length as the animals age. These phenotypes indicate an imbalance of proliferation 
over differentiation similar to glp-1/Notch gain-of-function mutations (Berry et al., 
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1997; Pepper et al., 2003), and are distinct from tumors that arise from a return to 
proliferation from meiotic development (Francis et al., 1995a; Subramaniam and 
Seydoux, 2003) or that result from disrupting the function of multiple factors acting 
downstream of glp-1 to promote meiotic entry (Kadyk and Kimble, 1998; Eckmann et 
al., 2004; Hansen et al., 2004a). 
 We confirmed that the cells suspected to be ectopic proliferating cells are 
cycling by testing for incorporation of the nucleotide analog, EdU, which labels cells 
in S-phase of the cell cycle (Salic and Mitchison, 2008).  In wild type germlines, a 3 
hour pulse of EdU labels most cells in the proliferative zone, but not in the adjacent 
meiotic region (Figure 1B).  The suspected ectopic proliferating cells in the mett-
10(oz36) mutant label with EdU within a 3 hour period, demonstrating that they are 
cycling (Figure 1C).  Because EdU labels cells both in mitotic as well as meiotic S-
phase, we further characterized these cells by staining for additional mitotic and 
meiotic markers.  Ectopic phospho-histone-3 (pH3) nuclei were observed in mett-
10(oz36) mutants, consistent with ectopic mitosis (Figure 1D-E).  Furthermore, these 
cells were negative for the meiotic marker, GLD-1 (Hansen et al., 2004b).  Together, 
these data suggest that the mett-10(oz36) mutation causes the proliferation of germ 
cells which should otherwise have entered meiosis.  Because the C.elegans germline 
stem cells have not been unequivocally identified, we cannot definitively attribute our 
phenotype to overproliferation of the germline stem cells themselves, rather than a 
potential transient amplifying population.  However, the degree of tumor formation 
seen in older animals, coupled with the similarity of the overproliferative phenotype 
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to that of glp-1/Notch gain-of-function mutants suggests that mett-10(oz36) may 
affect stem cell fate specification. 
 We cloned mett-10 by genetic mapping, cosmid rescue, and sequencing of 
candidate genes.  Several lines of evidence indicate that the gene affected by the oz36 
mutation is ZK1128.2, the ortholog of human Methyltransferase-10 Domain 
Containing protein (METT10D) (Figure 2A).  First, the mutation responsible for the 
tumorous phenotype genetically maps to a genomic region containing ZK1128.2 (data 
not shown).  Second, a transgene containing the ZK1128.2 coding region rescues the 
mett-10(oz36) mutant phenotype (Table 1).  Finally, sequencing of the oz36 allele, as 
well as other mutations in the same complementation group (see below), all reveal 
molecular lesions within the ZK1128.2 coding region (Figure 2B). 
 The N-terminal domain of human METT10D was crystallized in complex 
with S-adenosyl methionine (SAM), the substrate used by SAM-dependent 
methyltransferases to catalyze the transfer of a methyl group to a wide variety of 
substrates, including protein, DNA, RNA, small molecules and lipids (Martin and 
McMillan, 2002; Wu et al., To be published.).  Based on sequence conservation and 
secondary structure prediction, C.elegans METT-10 is predicted to bind SAM (Figure 
2A).   Furthermore, both human and C.elegans METT-10 contain a full “SAM-
dependent methyltransferase fold”, including conserved protein motifs known to be 
responsible for the catalysis of the methyl-transfer (Figure 2A; Malone et al., 1995).  
With only two known exceptions, proteins containing the SAM-dependent 
methyltransferase fold act as methyltransferases (see Discussion). Thus, it is highly 
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likely that METT-10 acts as a methyltransferase in C. elegans, although the 
biochemical nature of the substrate is unknown at this time.  
 
Loss of mett-10 function results in multiple temperature-sensitive phenotypes 
 The oz36 mutation creates a premature stop codon that truncates the protein 
shortly after the putative methyltransferase domain. While the mett-10(oz36) mutant 
is tumorous at lower temperatures (Table 1),  at 25˚C it behaves as a loss-of-function 
and fails to complement a deficiency (nDf40).  At this non-permissive temperature, 
mett-10(oz36) animals are sterile (Ste) or maternal-effect lethal (Mel), with multiple 
somatic phenotypes including slow growth (Gro), a protruding vulva (Pvl), and 
distension of the intestinal lumen (data not shown, Table 2, Figure 3B,E). 
 We identified two additional mett-10 alleles by testing uncloned Ste/Pvl 
mutants mapping to the same genetic region for complementation of mett-10(oz36) at 
25˚C (Figure 2B). mett-10(g38) was first identified as let-42 in previous screens for 
maternal effect lethal mutations (Cassada et al., 1981).  mett-10(oj32) was isolated in 
a screen for temperature sensitive sterile and uncoordinated mutants and was 
originally named stu-18 (O'Connell et al., 1998).  Based on sequence conservation 
between C. elegans METT-10 and Human METT10D, the oj32 mutation (G110R) 
disrupts a conserved glycine that binds to S-adenosyl methionine, the substrate used 
by SAM-dependent methyltransferases, and thus should compromise enzymatic 
activity (Figure 2, Malone et al., 1995). 
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 Two deletion alleles were obtained from the Japanese National Bioresource 
Project (tm2697) and the C. elegans gene knockout consortium (ok2204) (Figure 2B).  
The tm2697 deletion is an internal in-frame deletion C-terminal to the core of the 
conserved methyltransferase domain. The ok2204 deletion removes the entire 
methyltransferase domain, and we believe that it is essentially a null allele. 
 Like mett-10(oz36), all other mett-10 alleles exhibit a temperature sensitive 
Ste/Mel/Pvl phenotype (Table 2, Figure 3C,F).  Germline sterility in mett-10 loss-of-
function mutants appears to be a result of abnormalities in gonad morphology and 
defects in germ cell meiotic development.  At 25˚C, 30% of mett-10(ok2204) 
germlines have at least one extra protrusion in this distal gonad (Figure 4A-B).  
Moreover, many germlines contain pachytene cells in the proximal-most region of the 
germline, normally occupied by diakinetic oocytes (data not shown).  In situations 
where proximal mett-10(ok2204) germ cells progress from pachytene to diplotene,  
there is often a disruption of normal linear oocyte organization (Figure 4E-F).  
 In addition to abnormalities in their meiotic development, and unlike mett-
10(oz36) germline tumors,  mett-10(ok2204) germ cells appear to have difficulty in 
progressing through the mitotic cell cycle.  At all temperatures, the proliferative zone 
of mett-10(ok2204) germlines contain abnormally large, diffuse nuclei (Figure 4B,D).  
Because this nuclear morphology is associated with cell cycle arrest (Gartner et al., 
2000; Moser et al., 2009), we tested if these cells were actively cycling by labeling 
with EdU and co-staining for phospho-histone-3.  We found that these large cells do 
not incorporate EdU during a time period sufficient to label essentially all 
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proliferative zone nuclei in wild type germlines and are not pH3 –positive (Figure 
4C-D).  Together, these data suggest that these large nuclei arrest at some point other 
than M-phase of the cycle, and thus, that METT-10 may normally promote mitotic 
cell cycle progression.  Overall, mett-10 loss-of-function germlines are quite small at 
25˚C, suggesting that METT-10 may contribute to the execution of proliferation per 
se.  
 In additional to the developmental defects described above, we observed that 
mett-10 mutants exhibit defects in susceptibility to RNA interference (RNAi) at all 
temperatures.  To better characterize this phenotype, we tested multiple mett-10 
alleles for their susceptibility to dsRNA directed against the somatic gene, unc-22, 
and the germ line gene, gld-1.  We found that mutations in mett-10 have strong 
effects on germ line RNAi, but relatively mild effects on the soma (Figure 5), 
suggesting that METT-10 normally functions to promote the RNA interference 
pathway in the germ line.  Significantly, mett-10 RNAi defects are not suppressed by 
a mutation in eri-1, a nuclease that acts downstream to the “core” RNAi machinery to 
degrade siRNAs generated by exogenous RNAi, suggesting that METT-10 may 
function in the generation of functional siRNAs (Figure 5 and Kennedy et al., 2004).    
Consistent with their loss-of-function nature, mett-10 somatic and germline 
defects are suppressed by a wild-type mett-10 transgene (Table 2, data not shown) 
and, with the exception of maternal effect embryonic lethality and RNAi-resistance, 
mett-10 phenotypes are maternally rescued (Table 2). Significantly, while all alleles 
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exhibit the Ste/Mel/Pvl phenotype with variable penetrance at 25˚C, in contrast to 
mett-10(oz36), none are tumorous under any temperature condition (Table 3).  
 
mett-10(oz36) likely produces a “poisonous” product 
 Since mett-10(oz36) is the only allele that is tumorous on its own, we thought 
it possible that the mutation might confer a novel activity unrelated to the normal 
mett-10(+) function.  However, the evidence indicates that this is not the case.  If 
mett-10(oz36) is tumorous because it has acquired a new function, then the tumorous 
phenotype should be unmodified by a wild type copy of mett-10.  However, the 
tumorous phenotype of mett-10 (oz36) is recessive and is also completely suppressed 
by a wild type transgene (Table 1).   
 Genetic experiments indicate that mett-10(oz36) likely encodes a product that 
poisons processes in which mett-10(+) normally participates.  If mett-10(oz36) 
encodes a poisonous product, the tumorous phenotype should depend on the dosage 
of mett-10(oz36). To increase the effective dose of mett-10(oz36), we took advantage 
of the fact that the oz36 mutation is a premature stop codon and that the transcript 
should be degraded by nonsense-mediated decay (NMD).  Disruption of NMD should 
therefore result in increased production of a ‘poisonous product’ (Hodgkin et al., 
1989; Page et al., 1999).  We observed that genetic disruption of NMD by the smg-
2(e2008) mutation significantly enhances the overproliferation phenotype of mett-
10(oz36) to 98% penetrance (Table 1).  NMD-disruption also enhances the degree of 
tumor formation in the mutants, with much larger tumors forming in smg-2(e2008); 
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mett-10(oz36) animals than in mett-10(oz36) animals alone (Figure 6B-C).  
Interestingly, even in an NMD-defective background, mett-10(oz36) is recessive, 
indicating that wild type METT-10 fully suppresses the tumorous phenotype (Table 
1).  This suggests that the tumorous phenotype of mett-10(oz36) mutants may be 
caused by the simultaneous loss of METT-10 function, and the poisoning of another 
protein by METT-10(oz36).  Supporting this idea, heteroallelic mett-10(oz36)/mett-
10(g38) mutants exhibit a partially penetrant tumorous phenotype that is more severe 
than mett-10(oz36)/mett-10 (+) and less severe than mett-10(oz36) homozygotes in an 
NMD-defective background (Table 1). 
 NMD-disruption also enhances maternal-effect embryonic lethality in the 
mett-10(oz36) mutant, as the few progeny laid by smg-2(e2008); mett-10(oz36) 
mothers at 15˚C or 20˚C die late in embryogenesis or shortly after hatching with a 
variety of abnormalities (Figure 3G-I).  This suggests that mett-10(oz36) expression 
may also disrupt some aspect of embryonic development. 
 
METT-10 inhibits germ cell proliferative fate  
 A straightforward interpretation of the mett-10(oz36) tumorous phenotype is 
that wild type METT-10 inhibits specification of germ cell proliferative fate.  
However, because the mett-10(oz36) allele forms a product that poisons other 
processes, it was also possible that it may indirectly affect proliferative fate 
specification.  To address this possibility, we tested if mett-10 loss-of-function alleles 
were  also compromised for the proliferative/meiotic fate decision.  Because none of 
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these alleles are tumorous on their own, we tested their ability to enhance a genetic 
background sensitized for the tumorous phenotype by an elevation of glp-1/Notch 
activity [glp-1(oz264)](Kerins, 2006).  We found that mett-10 alleles significantly 
enhance the glp-1(oz264) tumorous phenotype at 20˚C (Table 3), demonstrating that 
METT-10 normally either inhibits germ cell proliferative fate or promotes meiotic 
entry. 
 Our conclusion that METT-10 normally acts to inhibit germ cell proliferation 
and/or promote meiotic entry is further supported by our finding that mett-10 loss-of-
function alleles can partially suppress the premature meiotic entry phenotype of a 
temperature-sensitive glp-1 loss-of-function mutant [glp-1(bn18)] (Kodoyianni et al., 
1992; Qiao et al., 1995).  Adult glp-1 (bn18) animals raised at 20˚C and shifted to 
25˚C for six hours have minimal proliferative zones and an absence of nuclei in M-
phase (as evidenced by an absence of phospho-histone-3 (pH3)-positive nuclei) 
because removal of glp-1/Notch signaling induces all germ cells to enter meiosis 
(Figure 7E,F,J; P. Fox and T. Schedl, unpublished data; Kodoyianni et al., 1992; Qiao 
et al., 1995).  However, we observed pH3-positive nuclei, albeit reduced in number, 
in glp-1(bn18) mett-10(g38) double mutants after a six hour shift, despite equivalent 
numbers of pH3-positive nuclei in glp-1(bn18) and glp-1(bn18) mett-10(g38) 
unshifted controls (Figure 7G,H,J).  The reduction in overall proliferative zone size 
and number of pH3-positive nuclei in glp-1(bn18) mett-10(g38) germlines upon 
temperature-shift suggests that germ cells are still induced to enter meiosis upon 
removal of glp-1 signaling, although with different temporal dynamics; in support of 
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this, longer shifts of glp-1(bn18) mett-10(g38) animals result in the meiotic entry of 
all germ cells (Figure 7I). 
 Given the central role of glp-1/Notch signaling in the specification of germ 
cell proliferative fate, we sought to determine if METT-10 normally acts downstream 
of, upstream of, or in parallel to glp-1 to inhibit germ cell proliferative fate.  Several 
lines of evidence indicate that it is unlikely that GLP-1 normally acts to inhibit 
METT-10.   The first makes use of the fact that METT-10(oz36) acts similarly to a 
dominant negative protein, in that increased expression of the mutant protein drives 
the overproliferation phenotype towards the mett-10 loss-of-function direction.  Thus, 
if GLP-1 acts upstream of METT-10, we would not expect the mett-10(oz36) 
tumorous phenotype to be dependent on glp-1 activity. However, we find that tumor 
formation in the mett-10(oz36) background is exquisitely dependent on glp-1 
signaling;  glp-1(bn18) fully suppresses the smg-2(e2008); mett-10(oz36) tumorous 
(but not the embryonic lethality) phenotype at the permissive temperature of 20˚C 
(Table 1, Figure 6C-E), suggesting that METT-10 may negatively regulate glp-1 
signaling to inhibit the specification of proliferative fate. 
 The idea that METT-10 acts upstream of or in parallel to glp-1 signaling to 
inhibit germ cell proliferation is further supported by our analysis of genetic 
interactions between mett-10 and the genetic pathways that function downstream of 
glp-1 to redundantly promote meiotic entry.  These pathways are defined by the genes 
gld-1 and gld-2. In animals that have lost either gld-1 or gld-2, germ cells enter 
meiosis, but do not undergo normal meiotic progression (Francis et al., 1995b; Kadyk 
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and Kimble, 1998).  Germ cells that have lost both gld-1 and gld-2 fail to enter 
meiosis, resulting in germline tumors that are independent of glp-1 activity (Kadyk 
and Kimble, 1998; Hansen et al., 2004a).  We made double mutants between mett-
10(oz36) and null alleles of gld-1, gld-2, and gld-3 (which acts in the gld-2 pathway) 
(Eckmann et al., 2004).  Since gld-1(q485) hermaprodites have germline tumors that 
are due to a return to mitosis, while males are unaffected (Francis et al., 1995a), we 
analyzed gld-1(q485); mett-10(oz36) males and found that mett-10(oz36) does not act 
redundantly with gld-1 to promote meiotic entry (Table 4).  Furthermore, we found 
that while gld-2(q497) enhanced the mett-10(oz36) tumorous phenotype, this was 
completely suppressible by a reduction in glp-1 activity introduced either by the glp-1 
null allele, glp-1(q175), or even the temperature-sensitive glp-1 hypomorph, glp-
1(bn18), raised at the permissive temperature of 20˚C (Figure 8, Table 4).  Results 
similar to those for gld-2 were observed for gld-3 (Table 4). 
 
METT-10 is a nuclear protein expressed in many cell types 
 To localize the METT-10 protein in vivo, we expressed a GFP-tagged version 
of METT-10 under control of the endogenous promoter (see Methods) as an 
extrachromosomal array.  We found that METT-10::GFP is a nuclear protein 
expressed in many of the same tissues where mett-10 disruption causes phenotypic 
abnormalities, including the intestine, vulva, and cells of the somatic gonad including 
the distal tip cell, gonadal sheath cells, and spermatheca (Figure 9A-E). 
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To visualize METT-10 expression in the germline, where extrachromosomal 
arrays are often silenced relative to somatic copies (although mett-10::gfp  is weakly 
expressed in the germline from an array), we generated an integrated version of  
pmett-10:mett-10::gfp.  METT-10::GFP expression rescues all mett-10 mutant 
phenotypes (Tables 1-3).  The observed germline localization of METT-10 is 
consistent with its role in inhibition of germ cell proliferative fate; METT-10::GFP 
protein levels are low in the distal proliferative zone and increase as cells enter 
meiosis, although some proliferative nuclei are positive (Figure 10).  METT-10::GFP 
persists throughout meiotic prophase as a predominantly nuclear protein that does not 
colocalize with DNA (Figures 9F & 11). 
 The germ line expression pattern of METT-10 is altered in both glp-1 loss-of-
function and gain-of-function mutant backgrounds.  In line with our previous 
observation that METT-10 accumulates as germ cells enter meiosis, we find that in 
shifted glp-1(bn18) animals in which almost all germ cells have entered meiosis, 
nuclear METT-10 is uniformly detected in distally located meiotic nuclei (Figure 10).  
However, there is also an increase in METT-10 in distal nuclei when we shift the glp-
1 gain-of-function mutant, glp-1(ar202), to 25˚C to induce tumor formation, although 
patches expressing low METT-10 levels can be found (Figure 10).  It is likely that 
this represents an expansion of the normally small proliferative zone population that 
expresses METT-10 and that may require its function for normal cell cycle 
progression.  Our finding that METT-10 expression does not inversely correlate with 
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levels of GLP-1 activity further supports our hypothesis that METT-10 functions 
upstream of or in parallel to GLP-1 to antagonize its pro-proliferative functions. 
 
METT-10 acts in the germline to inhibit germ cell proliferative fate 
 Since METT-10 is expressed in both the germline and the soma, including 
cells of the somatic gonad that can affect germ cell fate (McCarter et al., 1997; 
Killian and Hubbard, 2004; Voutev et al., 2006), we used mosaic analysis to 
determine whether METT-10 acts in the soma or the germline to inhibit germ cell 
proliferative fate.  We carried out mosaic analysis by taking advantage of the fact that 
in C. elegans, injected DNA forms extrachromosomal arrays that are imperfectly 
transmitted during cell division (Yochem and Herman, 2005).  To form marked 
extrachromosomal arrays carrying wild type mett-10, we co-injected a rescuing mett-
10 (+) construct with a construct carrying the sur-5::GFP cell autonomous marker 
that is expressed in the nuclei of almost all somatic cells (Yochem et al., 1998). We 
found that, even with loss in the somatic gonad, the presence of the sur-5::GFP; mett-
10(+) array  in the germline (detected by transmission of the array to progeny) fully 
suppresses the tumorous phenotype of the smg-2(e2008); mett-10(oz36) double 
mutant (Figure 12).  Conversely, expression of mett-10 (+) in cells of the somatic 
gonad did not suppress the smg-2 (e2008); mett-10(oz36) tumorous phenotype in the 
event of germline loss (Figure 12) .  We conclude that METT-10 acts in the germline 
to inhibit the specification of proliferative fate. 
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DISCUSSION 
Unlike the post-mitotic soma, the adult C. elegans germline is a dynamic 
system; germ cells proliferate through mitotic cell division to maintain their 
population, and at some frequency, switch to meiosis to produce gametes (Crittenden 
et al., 2003; Hansen and Schedl, 2006; Kimble and Crittenden, 2007). The temporal 
and spatial dynamics of this decision, as well as the conservation of the Notch 
pathway that governs germ cell proliferation, makes it an excellent system to study 
the genetic architecture governing stem cell proliferation and fate specification. Here 
we identify a role for the previously uncharacterized, though highly conserved, 
METT-10 putative methyltransferase in inhibiting the choice of proliferative fate in 
the C. elegans germline.   In addition to its role in proliferative fate specification, we 
find that METT-10 is essential for normal germ line RNAi sensitivity, development 
of the vulva, somatic gonad, and embryo, and contributes to the progression of germ 
cells through both mitosis and meiosis.  The role of METT-10 in promoting mitotic 
cell cycle progression, while inhibiting the specification of proliferative fate, 
delineates a genetic difference between the developmental decision of proliferate fate 
specification and the process of cell proliferation per se. 
 
METT-10 acts as an inhibitor of germ cell proliferative fate in C. elegans 
Likely by way of stem cell fate specification, germ cell proliferation is 
promoted by the conserved glp-1/Notch signaling pathway (Crittenden et al., 2003; 
Hansen and Schedl, 2006; Kimble and Crittenden, 2007). One approach to identify 
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regulators of the germ cell proliferation is to study mutations that phenocopy the 
germ cell overproliferation phenotype observed in Notch gain-of-function mutants 
(Berry et al., 1997; Pepper et al., 2003).  mett-10(oz36), which leads to the formation 
of late-onset tumors, phenocopies the phenotype of glp-1 hyperactivation.  
Interestingly, while we can demonstrate that METT-10 normally plays a role in 
regulating germ cell proliferative fate (see below), mett-10(oz36) is a unique mett-10 
allele in that it is the only allele that is ever tumorous on its own. 
 Because mett-10(oz36) has, with respect to germline proliferation, a 
phenotype more severe than the null,  mett-10(oz36) must have additional properties 
beyond simple loss of METT-10 function that contribute to the tumorous phenotype. 
Our genetic analysis indicates that mett-10(oz36) not only results in a loss of normal 
METT-10 function, but also produces a protein that functionally poisons or interferes 
with an unknown factor(s) to cause germline tumors; thus, the overproliferation 
observed in mett-10(oz36) mutants is likely a synergistic phenotype that results from 
simultaneous loss of mett-10 function and the function of at least one other unknown 
factor.  Our analysis here makes multiple predictions that will be helpful for the 
identification of such a factor(s), including not only that disrupting its function should 
enhance overproliferation of mett-10 simple loss-of-function alleles, but also that it 
may physically interact with METT-10(oz36).  The fact that it took this special allele 
to recapitulate the glp-1/Notch gain-of-function phenotype highlights the redundancy 
governing glp-1 signal inhibition and germ cell fate specification and suggests that 
glp-1 occupies a unique “constriction point” in this complex genetic network.  This is 
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further supported by the identification of many negative regulators of Notch signaling 
that act at multiple steps in the signal transduction process, as well as the redundancy 
between the downstream pathways controlling meiotic entry (Sundaram and 
Greenwald, 1993; Hubbard et al., 1997; Crittenden et al., 2003; Hansen and Schedl, 
2006; Macdonald et al., 2008).   
 Although it took a unique allele to identify the role of mett-10 in inhibition of 
germ cell proliferative fate, genetic analysis indicates that METT-10 normally 
functions in this process.  We find that mett-10 loss-of-function alleles can enhance 
the tumorous phenotype of glp-1 gain-of-function mutations, while suppressing 
premature meiotic entry upon reduction of glp-1 signaling.   
 How does METT-10 inhibit germ cell proliferation?  Our observation that 
METT-10 accumulates in nuclei as germ cells enter meiosis suggests that METT-10 
may function in the nucleus to promote a switch from proliferative to meiotic fates.  
One possibility is that it inhibits the pro-proliferative functions of active glp-1/Notch 
signaling, since mett-10-associated overproliferation phenotypes resemble glp-1 
hyperactivation and are exquisitely dependent on glp-1 activity.  Moreover, genetic 
pathway analysis suggests that mett-10 does not function in any of the characterized 
meiotic entry pathways that act downstream of glp-1 signaling.  While these data 
suggest that METT-10 may negatively regulate glp-1/Notch signaling, it is still 
possible that it acts in parallel to GLP-1.  Moreover, we cannot say whether 
METT-10 inhibits Notch signaling in general, as we were unable to detect clear 
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genetic interactions with alleles of lin-12, the other C. elegans Notch receptor 
(Methods).  
 Molecularly, it is likely that METT-10 functions as a methyltransferase, and 
methylation is probably important for its function in proliferative fate specification.  
METT-10 contains a well-conserved SAM-dependent methyltransferase fold, which 
has been shown to bind SAM in the human protein (Wu et al., To be published.).  The 
mett-10(oj32) mutation, which disrupts a key SAM-binding residue, also disrupts the 
balance between germ cell proliferation versus meiotic entry when examined in a 
weak glp-1 gain-of-function genetic background.  Almost all of the many 
characterized proteins that contain a SAM-dependent methyltransferase fold function 
as methyltransferases (Martin and McMillan, 2002). The two notable exceptions 
include putrescine aminopropyltransferase (PAPT), which binds a decarboxylated 
form of SAM (and not SAM itself) to catalyze the transfer of an amino-propyl group, 
rather than a methylgroup, during spermidine synthesis (Korolev et al., 2002), and 
Dnmt2, which contains a full methyltransferase fold, binds SAM, but lacks detectable 
DNA methyltransferase activity (Dong et al., 2001).  Although methyltransferases 
can methylate protein, nucleic acid, small molecules, and lipids, in the absence of 
close homologs with known functions and target specificity, the biochemical nature 
of their target substrates cannot be easily predicted from protein or sequence structure 
(Martin and McMillan, 2002).  Thus, it is currently unclear what METT-10 
methylates if it functions as a methyltransferase.   
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Defects in proliferative fate specification are unlikely to be a downstream 
consequence of the mett-10(-) RNAi defect 
At all temperatures, mett-10 mutants are germ line RNAi resistant.  However, 
the role of METT-10 in RNAi is unlikely to be directly responsible for its phenotype 
with regard to germ cell proliferation.  There is no correlation between degree of 
RNAi-defect and degree of overproliferation for mett-10 alleles.  In addition, RNAi-
mediated depletion of the C. elegans DICER homolog, dcr-1, does not enhance the 
tumorous phenotype of the glp-1 gain-of-function allele, glp-1(oz264) (data not 
shown).  Finally, ego-1, an RNA-dependent RNA polymerase the contributes to 
germline RNAi, acts in the opposite direction to mett-10 with respect to germ cell 
proliferation; ego-1 was isolated as an enhancer of premature meiotic entry phenotype 
of glp-1 loss-of-function, and strong ego-1 alleles exhibit premature meiotic entry 
(Vought et al., 2005).  Thus, it is unlikely that a general RNA interference defect is 
responsible for the imbalance of proliferation over differentiation in mett-10 mutants, 
although it is possible that the same biochemical or cellular functions of mett-10 
underlie both phenotypes. 
 
Loss of METT-10 function results in a diverse set of developmental phenotypes 
 In addition to inhibiting proliferative fate in the distal germline, mett-10 
functions in multiple developmental contexts.  The phenotype of mett-10 loss-of-
function mutants, including abnormal morphology of the vulva and gonad, as well as 
multiple defects in germ cell and embryonic development, are a testament to the 
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potential diversity of mett-10 functions and targets.  Interestingly, many of the defects 
observed in these mutants, specifically those involving vulval morphogenesis and 
apparent defects in mitotic progression of germ cells, are associated with defects in 
cell division.  Multiple screens for cell division mutants have been based on this 
observation, including the one that lead to the identification of the mett-10(oj32) 
allele (O'Connell et al., 1998; Fay and Han, 2000).  This potential role for mett-10 in 
enabling cell division, coupled with its developmental role as an inhibitor of 
proliferative fate, highlights the importance of distinguishing the specification of 
developmental cell fates from the cellular mechanisms that ensure their proper 
execution. 
 
 
MATERIALS AND METHODS 
General worm culture and genetics 
 Standard procedures for culture and genetic manipulation of C. elegans strains 
were followed (Brenner, 1974). To generate and screen for tumorous mutants, N2 
Bristol animals were mutagenized with 50mM EMS, and a dissecting microscope was 
used to screen an aged F2 generation for tumorous animals (Francis et al., 1995a).  
For analysis of temperature sensitive phenotypes, hermaphrodites were allowed to lay 
eggs overnight at 20˚C, were removed, and the plates were shifted to 25˚C for the life 
of the F1 generation and phenotypes were scored at 1 day past the L4 stage at 25˚C.  
All experiments analyzed only hermaphrodite germlines with the exception of the 
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enhancement of gld-1(q485), in which male germlines were analyzed.  However, 
germline tumors were observed in rare, spontaneous smg-2(e2008); mett-10(oz36) 
males, indicating that the effect of the oz36 mutation is not sex-specific.   
Complementation testing between mett-10(oz36) and other mett-10 alleles was done 
by crossing potential mett-10 alleles to the hT2[qIs48]gfp balancer, and then crossing 
gfp(+) males to an unc-32(e189) mett-10(oz36) strain.  Non-green, non-unc 
hermaprodite progeny were picked to a new plate and shifted to 25˚C. To examine the 
interaction between mett-10 and lin-12, we built double mutants between the lin-
12(n379) gain-of-function and mett-10(g38) or mett-10(oz36).  No enhancement of 
the multi-vulval phenotype of lin-12(n379) was observed, although mett-10(-)lin-
12(n379) animals lacking maternal gene product were very sick, grew slowly, and 
had few progeny.  mett-10 alleles obtained from the knockout consortium and NBP-
Japan were cleaned up by outcrossing to N2 Bristol 3X or recombining the markers 
unc-32 and dpy-18 on and off the third chromosome.  Strain constructions were 
verified by single worm PCR and sequencing of alleles.  
Alleles used in this study by chromosome:  
I: smg-2(e2008), gld-1(q485), gld-2(q497) 
II: gld-3(q730) 
III: lin-12(n379), glp-1(oz264), glp-1(bn18), glp-1(q175), unc-32(e189), unc-
36(e251), mett-10(oz36), mett-10(g38), mett-10(tm2697), mett-10(ok2204), mett-
10(oj32), unc-119(ed3), dpy-18(e364), nDf40 
IV: eri-1(mg366) 
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Integrated Transgenes: ozIs7[pmett-10:mett-10::gfp; unc-119(+)] [chromosome I] 
Extrachromosomal arrays: ozEx66 [pmett-10:mett-10::gfp; unc-119(+)], 
ozEx63[pmett-10:mett-10;sur-5::gfp; unc-119(+)] 
 
RNA interference and Western Blot Analysis 
Clones for feeding RNAi against unc-22 and gld-1 were generated by PCR 
amplification and cloning of 1kb exonic sequences into the pPD128.36 double T7 
promoter vector.  Clones were sequenced to verify identity, and transformed into the 
E. coli host HT115(DE3).  Feeding RNAi was performed at 20˚C as previously 
described (Lee et al., 2007).  Gravid adults were placed on RNAi plates and allowed 
to lay overnight before removal.  F1 L4 hermaphrodites were transferred onto fresh 
RNAi plates, allowed to age for 24 hours, and then scored quantitatively for either 
degree of paralysis (unc-22) by dissecting microscope or for phenotypes associated 
with gld-1 dysfunction, including small oocytes and germ line tumors by DIC 
microscopy.  To quantitate degree of GLD-1 knockdown, 100 animals were washed, 
boiled in 2X SDS sample buffer, and loaded onto an SDS-page gel.  After transfer, 
GLD-1 was detected by using a Rabbit anti-GLD-1 antibody at 1:1000, while the 
LMN-1 control was detected using guinea pig anti-Celamin at 1:10,000. 
 
Mapping of SAM-binding residues on C. elegans METT-10 
 Because of their structural nature and relatively low sequence conservation, 
the mapping of previously characterized methyltransferase motifs (reviewed in 
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(Malone et al., 1995) onto C. elegans METT-10 was done primarily by aligning the 
C. elegans protein to human METT10D, a portion of which was crystallized in 
complex with S-adenosyl methionine  (SAM) by the Structural Genomics Consortium 
[Structure (PDB 2H00) which can be found at: 
http://www.rcsb.org/pdb/explore.do?structureId=2H00].  This was aided by 
secondary structure prediction using Jpred3 
[http://www.compbio.dundee.ac.uk/~www-jpred/]. As many methyltransferase motifs 
are defined by their interaction with SAM, we examined the METT-10-SAM 
interaction interface using RSCB ligand Explorer (available as a link through the 
above website), which also served to define which residues are predicted to be 
essential for SAM-binding. 
 
Immunohistochemistry 
Germline dissection, fixation, and staining was carried out as previously 
described (Lee et al., 2007).  Antibodies used were: monoclonal mouse anti-GFP 
(mAb3E6) from Invitrogen (Cat# A-11120), Rabbit anti-GLD-1 (Jones et al., 1996), 
Rabbit anti-phosphohistone-3 (Upstate, Cat#06-570), guinea pig anti-Celamin (gift 
from J. Liu, Cornell), and donkey anti-mouse Alexa 594, goat anti-rabbit Alexa 488, 
goat anti-rabbit Alexa 594, and goat anti-guinea pig-Alexa-488 obtained from 
Molecular Probes (Invitrogen, CA). For EdU labeling and co-staining with 
antibodies, we used a protocol modified from that of Sarah Crittenden (University of 
Wisconsin-Madison, personal communication).  To make EdU plates, a small culture 
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of MG1693 E. coli (thymidine deficient bacteria, available from the E.coli stock 
center) were grown overnight at 37˚C, and diluted 1/50 the next day in a solution of 1 
% glucose, 1.25 µg/ml thiamine, 0.5µM thymidine, 1mM MgSO4, and 20µM EdU in 
M9 minimal media.  This was grown at 37˚C for 24 hours in the dark, before being 
spun down, resuspended in a small volume of M9 and plated on 60mm M9 plates.  
For labeling and staining of proliferative cells, worms were picked on to EdU, 
washed off in PBS, dissected, and fixed for < 5 minutes in 3% paraformaldehyde/ /0.1 
M K2HPO4  (pH 7.2) at room temperature.  Germlines were taken through the normal 
antibody staining protocol, including DAPI-staining, followed by the Click-IT EdU 
reaction, performed according to the manufacturer’s instructions (Molecular Probes, 
Cat#A10027). 
 
Image capture and processing 
Fluoresence micrographs were taken on a Zeiss compound microscope using 
AxioPlan 2.0 imaging software and Hamamatsu camera. Each dissected and stained 
gonad was captured as a montage, with overlapping cell boundaries. The montages 
were then assembled in Adobe Photoshop CS3 and processed identically. The 
boundary of each montage was processed using a feather tool of 20 pixels for each 
image.    
Confocal images were captured on a Perkin Elmer Ultraview Confocal 
Microscope using a z-step of 1 micron.  Where stated, multiple slices were assembled 
into an extended focus image using Volocity image analysis software. 
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Construction of transgenes and generation of transgenics 
 To create the initial METT-10::GFP construct, the entire METT-10 genomic 
region, including 1.6 kb upstream and 1.9 kb downstream of the METT-10 coding 
region was amplified as two PCR products meeting at the translational stop using 
KOD DNA polymerase (Novagen, Cat # 71086), using the following primers: [ 5’ 
region: ATTA- NotI- GCGTCGTAGCCTGTGTTCAATTCC (F) and ATTA-
BamHI-TCGGCATATTAAATTTTTCAAATACTGCACTAG (R)] and [3’ region: 
ATTA-BamHI-TAAATAGCATAATTTTATTTATTCAATATTTATACC (F) and 
ATTA-NotI- GGATACTGTATGTACAACTGATCTCTGAGC (R)].  This 5.5 kb 
region includes parts, but not all, of the adjacent genes.  These fragments were 
digested with BamHI and NotI and ligated in a three-part ligation with NotI digested- 
pMM016 (Praitis et al., 2001), a plasmid containing the unc-119+ transformation 
marker, to create pMM016(mett-10+). GFP(ivs):FLAG was amplified from 
(pPD115.70, gift of Andrew Fire) and cloned into pMM016(mett-10+) using the 
BamHI site.  Proper orientation was determined by PCR, and the entirety of the mett-
10 region was sequenced to confirm integrity. To create low-copy integrated 
transgenic lines, the microparticle bombardment method was used (Praitis et al., 
2001).  
 
Mosaic analysis 
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 To generate arrays for mosaic analysis, pMM016 [mett-10+] was co-injected 
with pTG96 [sur-5::gfp] (gift of Min Han’s lab) at concentrations of 20ng/ul and 
80ng/ul, respectively.  These arrays were crossed into smg-2(e2008); mett-10(oz36) 
worms.  Green animals were cloned individually at the L4 stage.  After 2.5 days, 
plates were screened for animals with green embryos or progeny to determine if the 
array had passed through the germline.  Animals were segregated based on germline 
transmission, germlines were dissected, fixed briefly for 10’ in 3% paraformaldehyde 
to preserve GFP fluorescence, DAPI stained, and mounted for scoring of germline 
phenotype and GFP distribution. 
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Table 1: The mett-10 (oz36) tumorous phenotype is the result of a poisonous 
product 
Genotype temp (˚C) % Tum n 
mett-10(oz36) 15 72 107 
mett-10(oz36) 20 41 66 
mett-10(oz36)/+ 15 0 64 
mett-10(oz36)/+ 20 0 70 
ozIs7[mett-10::GFP]; oz36 15 0 76 
ozIs7[mett-10::GFP]; oz36 20 0 80 
mett-10(oz36)/mett-10(ok2204) 15 0 32 
mett-10(oz36)/nDf40 15 0 44 
smg-2(e2008); mett-10(oz36)/+ 20 0 54 
smg-2(e2008); mett-10(oz36)/mett-10(g38) 20 18 40 
smg-2(e2008); mett-10(oz36) 20 98 80 
smg-2(e2008);  glp-1 (bn18) mett-10(oz36) 15 0 128 
smg-2(e2008);  glp-1 (bn18) mett-10(oz36) 20 0 98 
Full genotypes of the mutant combinations are: unc-32(e189) mett-10(oz36)/ nDf40 
dpy-18(e364), unc-32(e189) mett-10 (oz36)/ mett-10(ok2204) dpy-18(e364), smg-
2(e2008); unc-36(e251) mett-10(oz36) / unc-119 (ed3), smg-2(e2008); unc-36(e251) 
mett-10(oz36)/ unc-32(e189) mett-10(g38). All animals were m+, i.e. came from 
mothers carrying a wild type copy of mett-10.  Animals grown at 15˚C were scored at 
3 days past L4 and animals grown at 20˚C were scored at 2 days past L4.   
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Table 2: Loss of mett-10 function leads to multiple, temperature sensitive 
phenotypes sensitive to maternal gene dose. 
genotype m temp 
% 
Pvl %Ste 
% 
Mel n 
mett-10(oz36) no 20 1 4 0 116 
mett-10(oz36) no 25 43 100 N.A. 103 
mett-10(oz36) yes 25 0 3 97 58 
mett-10(g38) no 20 2 7 0 59 
mett-10(g38) no 25 21 89 11 63 
mett-10(g38) yes 25 0 10 90 21 
mett-10(tm2697) no 20 10 19 0 133 
mett-10(tm2697) no 25 88 100 N.A. 142 
mett-10(tm2697) yes 25 0 2 98 60 
mett-10(oj32) no 20 0 18 0 71 
mett-10(oj32) no 25 11 100 N.A. 75 
mett-10(oj32) yes 25 0 0 100 53 
mett-10(ok2204) no 20 12 8 0 52 
mett-10(ok2204) no 25 98 99 N.A. 82 
ozIs7[mett-10::GFP];mett-10(ok2204) no 25 5 0 0 38 
mett-10(ok2204) yes 25 0 0 100 45 
m= endogenous maternal gene product; Pvl= Protruding vulva; Ste = Sterile (no embryos 
present); Mel = maternal effect lethal (lays dead embryos).  All animals were scored 1 
day past the L4 stage by DIC. 
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Table 3: mett-10 inhibits proliferative fate in the C. elegans germline 
Genotype temp(˚C) 
% 
Tum n 
glp-1(oz264) 20 1 100 
mett-10(ok2204) 15 0 54 
mett-10(ok2204) 20 0 68 
mett-10(oz36) 15 72 107 
mett-10(oz36) 20 41 66 
glp-1(oz264) mett-10(oz36) 20 100 72 
mett-10(oj32) 15 0 72 
mett-10(oj32) 20 0 48 
glp-1(oz264) mett-10(oj32) 20 49 96 
mett-10(tm2697) 15 0 68 
mett-10(tm2697) 20 0 76 
glp-1(oz264) mett-10(tm2697) 20 84 112 
mett-10(g38) 15 0 78 
mett-10(g38) 20 0 56 
glp-1(oz264) mett-10(g38) 20 89 47 
ozIs7[mett-10::gfp];glp-1(oz264) mett-10(g38) 20 0 56 
All animals were m+, i.e. came from mothers carrying a wild type copy of 
mett-10.  Animals grown at 15˚C were scored at 3 days past L4 and animals 
grown at 20˚C were scored at 2 days past L4.  
Tumorous (Tum) includes proliferation throughout the germline, although 
some germ cells in various meiotic stages may be observed. 
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Table 4: Genetic interactions between mett-10 and known meiotic entry genes. 
genotype % Tum n or reference 
mett-10(oz36) 41 66 
gld-1(q485)* 0 Francis et. al. (1995a) 
gld-1(q485); mett-10(oz36)* 0 21 
gld-2(q497) 2 Kadyk and Kimble (1998) 
gld-2(q497); mett-10(ok2204) 0 102 
gld-2(q497); mett-10(oz36) 100 98 
gld-2(q497); glp-1(bn18) mett-10(oz36) 0 97 
gld-2(q497); glp-1(q175) mett-10(oz36)** 0 44 
gld-3(q730) 0 Eckmann et. al. (2004) 
gld-3(q730); mett-10(oz36)# 100$ 47 
gld-3(q730); glp-1(q175) mett-10(oz36)** 0 28 
 *data from male germlines, as gld-1(q485) hermaphrodites have proximal proliferation due to 
a return to mitosis (Francis et.al, 1995a).                                                                               
**homozygous for unc-32(e189).                                                                                                                           
All data collected at 20˚C from animals with maternal mett-10 gene product, with the 
exception of gld-3 strains (#), which make synthetic proximal proliferation tumors with mett-
10, and do not exhibit an increase in the length of the distal proliferative zone ($). 
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Figure 1. mett-10 (oz36), a tumorous mutant. (A) A fluorescence micrograph of a 
dissected, DAPI-stained wild type adult C. elegans hermaphrodite germline, with 
schematic above. In the distal region proliferating germ cells (2) reside in close 
contact with the somatic distal tip cell (1).  At the transition zone (3), germ cells enter 
meiosis, and proceed through meiotic prophase (4) to give rise to sperm in the L4 
stage (6) and oocytes during adulthood (5).  (B&C) Fluorescence micrographs of 
distal germlines labeled for 3 hr with EdU from (B) wild type and (C) mett-10(oz36) 
animals.  White arrows mark the distal tip. (D-E) Extended focus projections of distal 
germlines from (D) wild type and (E) mett-10(oz36) animals stained for the M-phase 
marker phospho-histone-3 (pH3).  Yellow dotted lines indicate the approximate 
boundary of the proliferative and transition zones.  All images are from animals 
raised at 15˚C.  Scale bar = 20 microns. 
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Figure 2. C. elegans METT-10 encodes a putative methyltransferase. (A) 
Alignment of the methyltransferase-10 domain of C. elegans METT-10 (GenBank 
Acc# NP_499247), H. sapiens METT10D (GenBank Acc# NP_076991), and X. 
laevis MGC81116  (GenBank Acc# NP_001085334).  The architecture of the 
methyltransferase domain is shown both by identification of methyltransferase motifs 
(Malone et al., 1995), as well as secondary structure predictions with α-helices in 
pink and ß-sheets in green (see methods).  Motifs I, II, III, IV, V, and X were 
identified by examination of the Human METT10D N-terminal crystal structure 
(PDB 2H00), which did not include the region predicted to contain motifs VI and 
VIII (see Methods). Previous work suggests that Motifs X, I, and III are primarily 
responsible for binding to S-adenosyl methionine, (SAM) while Motifs IV, VI, and 
VIII are primarily responsible for enzyme catalysis (Malone et al., 1995). Red arrows 
show location of residues with significant contacts with SAM in the crystal structure 
of human METT10D. mett-10(oj32) mutates the contacting glycine (G110, large red 
arrow) in Motif I to an Arginine.  This residue normal provides direct contact with the 
methionine group of SAM.  The overall structure and ability to bind SAM appears 
highly conserved between orthologs, with the exception of an insertion of a predicted 
(*) α–helix between ß4 and a5 in C. elegans. Not depicted is the C-terminal half of 
the METT-10 protein, which may contain the target recognition domain, and is 
significantly less conserved between orthologs. (B) Domain architecture of METT-10 
marked with protein sequence changes caused by mett-10 alleles.  Gray shading 
highlights the conserved methyltransferase-10 domain. 
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Figure 3: Loss of mett-10 function causes multiple temperature-sensitive somatic 
defects.  Vulva of (A) wild-type (B) mett-10(oz36) and (C) mett-10(ok2204) animals 
raised at 25˚C.  mett-10 mutants have the protruding vulva (Pvl) phenotype (arrow). 
(D) A normal posterior region of intestine in a wild-type animal.  White arrows mark 
the borders of the intestinal lumen. (E) mett-10(oz36) and (F) mett-10(ok2204) 
animals raised at 25˚C have distended intestinal lumens containing visible bacteria.  
(G-H) Phenotypes of progeny of smg-2(e2008); mett-10(oz36) animals at 20˚C.  (G) 
Most embryos arrest during late embryonic development with visible vacuoles (black 
arrows), (H) embryos are often abnormal in size (see small embryo on left), and (I) 
the progeny that do hatch arrest shortly after with visible abnormalities (e.g. white 
arrow). 
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Figure 4: Germline phenotypes of mett-10(ok2204). (A) A one micron confocal 
slice of the distal end of a wild type germline stained with the meiotic marker GLD-1.  
(B) Confocal slices of representative distal germlines from mett-10(ok2204) m-z- 
animals raised at 25˚C and stained with an antibody against GLD-1.  Phenotypes 
range from small distal regions containing abnormally large nuclei (white arrows) to 
gross morphological abnormalities with multiple gonadal protrusions (larger yellow 
arrows).  Many of the protrusions stain with the meiotic marker GLD-1, suggesting 
that they are often filled with meiotic cells and do not represent duplications of the 
distal tip.   These gonad abnormalities are not observed for any mett-10 allele at 15˚C. 
(C) A confocal slice of a wild type germline labeled with EdU for 4 hours at 15˚C and 
stained with anti-phosphohistone-3 to mark cells in M-phase.  With 4 hours of 
labeling, essentially all cells within the proliferative zone are labeled.  (D) A mett-
10(ok2204) germline labeled with EdU for 4 hours at 15˚C and stained for phospho-
histone-3.  Large, diffuse nuclei are visible in the distal region (white arrows); these 
cells do not label with EdU in this time period and do not appear to be in M-phase 
(absent for pH3). (E) Fluorescence micrograph of a wild type proximal germline 
stained with an antibody against lamin to visualize oocyte nuclear positions.  Wild 
type animals produce a single row of oocytes.  (F) The proximal germline of a mett-
10(ok2204) animal shifted from 20˚C to 25˚ for 2 days as an L4.  Disorganization of 
the oocytes and abnormal chromosomal morphology are visible.  All scale bars = 20 
microns. 
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Figure 5: mett-10 disruption causes germ line RNAi resistance.  (A) Effect of 
feeding RNAi directed against the somatic gene unc-22.  Strong unc-22 knockdown 
causes partial paralysis and the “twitching” phenotype. (B) Effect of feeding RNAi 
directed against the germ line-specific gene, gld-1. (C) Quantitation of degree of 
GLD-1 knock down with Western analysis.  The eri-1(mg366) “enhanced RNAi” 
mutant does not suppress the mett-10 RNAi resistance phenotype. 
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Figure 6: mett-10(oz36)  overproliferation is glp-1 dependent. Fluoresence 
micrographs of germlines stained with DAPI to visualize DNA morphology (blue) 
and for the meiotic marker GLD-1 (green). (A, A’) in wild-type hermaphrodites, 
GLD-1 levels increase as germ cells enter meiosis and decrease as they transition 
from pachytene to diplotene (Jones et al., 1996). (B, B’) homozygous mett-10(oz36) 
animals raised at 15˚C exhibit a late-onset tumorous phenotype, as evidenced by an 
increase in length of the distal proliferative zone and a spatial delay in GLD-1 
accumulation. (C, C’) Disruption of nonsense-mediated mRNA decay with a mutation 
in smg-2 significantly enhances the penetrance (Table 1) and degree of tumor 
formation of mett-10(oz36) at 20˚C resulting in germlines containing proliferating 
cells throughout. (D, D’) At the permissive temperature of 20˚C,  glp-1(bn18) 
hypomorphic temperature-sensitive mutants have only slight reductions in  distal 
proliferative zone size. (E, E’) glp-1(bn18) fully suppresses the tumorous phenotype 
of smg-2(e2008); mett-10(oz36) animals at 20˚C.  Scale bar = 20 microns. 
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Figure 7. mett-10(g38) suppresses the temporal dynamics of premature meiotic 
entry in glp-1(bn18). (A-I) Extended focus projections of distal germ lines stained 
with DAPI to visualize DNA (blue) and for the M-phase marker phospho-histone-3 
(pH3) (red).  White dotted lines indicate the approximate boundary between the 
proliferative and transition zones as defined by DNA morphology. (A-D) wild-type 
and mett-10(g38) animals have similar proliferative zone size and number of pH3-
positive nuclei at 20˚C, and exhibit small decreases in the number of pH3-positive  
nuclei upon a six hour shift to 25˚C.  (E-F) Upon a six hour shift to 25˚C, no pH3-
positive nuclei can be found in glp-1(bn18).  (G-H) After a six hour shift to 25˚C, glp-
1(bn18) mett-10(g38) germ lines still contain pH3- positive nuclei and retain a longer 
proliferative zone than glp-1(bn18) alone.  (I).  After an 18 hour shift to 25˚C, no 
pH3-positive nuclei can be found in glp-1(bn18) mett-10(g38) germ lines and nuclear 
morphology is consistent with all cells entering meiosis with transition zone nuclei 
located immediately adjacent to the distal tip (white arrow). (J) Quantification of A-
H.  Scale bar = 20 microns. 
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Figure 8:  glp-1 activity is epistatic to gld-2(q497); mett-10(oz36) synthetic 
tumors. (A) Simultaneous removal of gld-2 and mett-10 function does not cause 
germ line tumors, but animals are sterile consistent with the meiotic defects seen in 
gld-2(q497) mutants alone (Kadyk and Kimble, 1998).  (B) The mett-10(oz36) allele 
does form synthetic tumors with the gld-2 null. (C) gld-2(q497); mett-10(oz36) 
tumors are suppressed by a weak glp-1 loss-of-function allele, glp-1(bn18). 
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Figure 9. METT-10::GFP is a nuclear protein expressed in multiple cell types. 
(A-C) Imaging of METT-10::GFP in live animals. (A) METT-10::GFP can be seen in 
intestinal nuclei (intestine delineated by dashed line), (B) in the developing vulval 
epithelium (white arrows; seen here at L4 stage), spermatheca (yellow dotted lines) 
and (C) the adult vulva. (D-G) Fluorescence micrographs of METT-10::GFP 
expression in the somatic gonad and germ line. METT-10::GFP is expressed in (D) 
sheath cell nuclei, (E) the distal tip cell (white arrow), and (F) oocyte nuclei.  Scale 
bar = 20 microns. 
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Figure 10. The pattern of METT-10::GFP accumulation in the distal germ line is 
altered in glp-1 mutants.  METT-10::GFP in the distal germ line. Proliferating germ 
cells were labeled with a 3 hr pulse of EdU (red). METT-10::GFP (green) 
accumulates in nuclei as cells enter meiosis, although some faint staining is also 
observed in some proliferative nuclei. (B) A 6 hour shift of glp-1(bn18) animals to 
25˚C results in almost all germ cells entering meiosis, and a concomitant shift in the 
pattern of METT-10 accumulation. (C) glp-1(ar202gf) animals shifted for a day to 
25˚C at the L4 stage form germ line tumors.  Increased distal METT-10 is also 
observed in many of these animals, although “low METT-10” patches are also 
observed (regions encircled by white dotted lines). Scale bar = 20 microns.  
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Figure 11: METT-10 is nuclear protein that does not colocalize with DNA.  
Confocal slices of germ cells in meiotic pachytene expressing METT-10::GFP and 
stained with mAB414 (which marks the nuclear pore, RED), anti-GFP (GREEN), and 
DAPI (BLUE) to visualize nuclear morphology.  Overlays show that METT-10::GFP 
localizes predominantly within the nucleus, but does not overlap with the DNA.  
Scale bar = 20 mi 
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Figure 12. mett-10 acts in the germ line to inhibit proliferative fate. To determine 
the focus of METT-10 action in proliferative fate decisions, we carried out mosaic 
analysis.  A GFP - marked extrachromosomal array ozEx63 was generated by co-
injection of a plasmid containing sur-5::gfp (Yochem et al., 1998) and a plasmid 
containing pmett-10:mett-10(+). The array was crossed into the smg-2 (e2008); mett-
10 (oz36) background. Animals were individually scored for presence of the array in 
the germ line (presence in progeny), cells of the somatic gonad (gonadal sheath and 
distal tip cell), and the intestine.  Location of array loss within the lineage was 
inferred by the absence of GFP in all scored tissues descending from a given cell. 
Germ lines were dissected, DAPI stained, and scored as Tumorous or Not Tumorous.  
Green circle indicates presence of array, while open circle indicates absence.  Loss of 
the rescuing array in the germ line lineage results in a failure to suppress the fully 
penetrant tumorous phenotype of the smg-2 (e2008); mett-10 (oz36) double mutant, 
while loss in the somatic gonad is tolerated. One animal had one tumorous germ line 
and one non-tumorous germ line, both with GFP+ somatic gonads.  We infer that this 
is likely a later loss in one of the germ line precursors Z2 or Z3. 
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Chapter 3: 
A role for dynein in the inhibition of germ cell proliferative fate 
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INTRODUCTION 
 C. elegans germ cells proceed through a well-orchestrated developmental 
program on their way to producing specialized gametes (Hubbard and Greenstein, 
2005).  The C. elegans gonad functions as an assembly line organized with a distal to 
proximal polarity with respect to the uterus (Figure 1A).  Proliferating germ cells, 
including the germ line stem cells, reside in the distal region of the gonad that forms 
the stem cell niche.  These cells self-renew through mitosis, or at a certain frequency, 
differentiate by entering meiosis and give rise to gametes after an extended meiotic 
prophase (Figure 1B).  As there is no evidence for asymmetric division of 
proliferating germ cells, differentiation is likely a consequence of progressive 
displacement away from the stem cell niche (Lin, 1997; Crittenden et al., 2006; 
Morrison and Kimble, 2006).  
The primary signal instructing germ cells to proliferate is activation of the glp-
1/Notch signaling pathway in the germ cells through interaction with the somatic 
distal tip cell that expresses the Notch ligand LAG-2, which provides the stem cell 
niche (Henderson et al., 1994; Hansen and Schedl, 2006; Kimble and Crittenden, 
2007).  Mutations that disrupt glp-1/Notch receptor function result in premature 
differentiation and meiotic entry of germ line stem cells (Austin and Kimble, 1987), 
while mutations that hyperactivate glp-1/Notch cause germ line tumors characterized 
by germ cell overproliferation (Berry et al., 1997; Pepper et al., 2003).  
 Multiple factors act to restrain GLP-1-dependent germ cell proliferation 
(Hansen and Schedl, 2006; Kimble and Crittenden, 2007).  The C. elegans mett-10 
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gene was initially characterized as an inhibitor of germ cell proliferative fate, but was 
also shown to play a role in promoting progression through mitotic cell division and 
meiotic development (Chapter 2).  mett-10  encodes a putative methyltransferase that 
is conserved in higher eukaryotes and a mutation that disrupts the binding pocket for 
S-adenosylmethionine compromises the balance between proliferative and meiotic 
fates (Chapter 2; Wu et al., To be published.).   METT-10 accumulates in nuclei as 
germ cells enter meiosis, consistent with its role in inhibiting proliferative fate and 
promoting meiotic progression (Chapter 2).  However, it is unclear how METT-10 
nuclear accumulation is controlled, or if it is essential for METT-10 activity. 
We find that inhibition of proliferative fate is also regulated by Dynein Light 
Chain-1 and its partner, Dynein Heavy Chain-1; DLC-1 upregulates mett-10 RNA 
levels and promotes the nuclear accumulation of METT-10 protein.  Cytoplasmic 
dynein is a large microtubule-associated motor complex that traffics organelles, 
proteins, and RNAs toward microtubule minus ends (Karki and Holzbaur, 1999; 
Carson et al., 2001; Vale, 2003).   Dynein is required for many cellular processes, 
including execution of mitotic cell division, a process necessary for cell proliferation 
(Gonczy et al., 1999; Karki and Holzbaur, 1999; Schmidt et al., 2005).  Thus, the 
unexpected role of dynein in the inhibition of germ cell proliferative fate 
demonstrates that proliferative fate is genetically separable from the act of mitotic cell 
division itself, and addresses how cellular machinery can implement developmental 
programs. 
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RESULTS 
Dynein Light Chain – 1 (DLC-1) inhibits germ cell proliferative fate 
To identify proteins that function to inhibit the proliferative fate and may act 
as functional partners of METT-10, we took advantage of available yeast two-hybrid 
data for all conserved worm proteins (Li et al., 2004), and compiled a list of proteins 
that interacted directly with METT-10 (primary interactors) and proteins that 
interacted with the primary interactors (secondary interactors) (Figure 2).  We 
reasoned that if any of these proteins function with METT-10, they may also inhibit 
proliferative fate.  To test this, we depleted each of the interacting proteins by RNAi 
in a genetic background sensitized to tumor formation by having excessive glp-1 
activity [glp-1(oz264gf)] ((Kerins, 2006).  We found five interactors that enhance the 
glp-1(oz264) tumorous phenotype, and thus normally act as inhibitors of the 
proliferative fate (Table 1 and Figure 2). This list of five interactors included dlc-1, an 
LC8-type dynein light chain, and a component of the dynein motor complex that 
participates in multiple processes, including minus-end directed protein trafficking 
and mitotic cell division (Karki and Holzbaur, 1999; Giannakakou et al., 2000; Vale, 
2003; Moseley et al., 2007; O'Rourke et al., 2007).   
Although DLC-1 depletion causes germ line tumors in the glp-1(gf) sensitized 
genetic background, it disrupts mitotic and meiotic processes in wild-type worms. In 
addition to apparent polyploid nuclei, which are larger and contain more DNA, many 
oocytes contained unpaired chromosomes (Figure 3, compare B and C). At first 
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glance, these findings appear paradoxical because the germ line tumors in the glp-1 
gain-of-function background require additional mitotic divisions. However, when we 
assessed the degree of DLC-1 knockdown using antibody staining, we found that the 
role of DLC-1 in inhibiting proliferative fate is uncovered in the glp-1 mutant 
background because only a slight decrease in DLC-1 is needed to enhance the 
tumorous phenotype of the glp-1(oz264) mutant without causing mitotic defects. In 
contrast, more severe knockdown affects both cell fate and cell division, leading to 
polyploidy (Figure 3F-J).  
 Although dynein light chains function within the context of the dynein motor 
complex, other functions independent of the motor complex have been described 
(Benashski et al., 1997; Herzig et al., 2000; Rayala et al., 2005; King, 2008). There 
are multiple light chains, but inhibition of proliferative fate was unique to DLC-1 
among the multiple dynein light chains we tested, including the closest dlc-1 paralog 
dlc-2, the Roadblock-type light chain dyrb-1, and the Tctex-type light chain, dylt-1 
(Figure 3A).  Strikingly, RNAi-mediated depletion of Dynein Heavy Chain-1 (DHC-
1), the essential motor component of the dynein motor complex activity (Gonczy et 
al., 1999), also increased tumor formation, suggesting that it plays a role in 
proliferative fate specification (Figure 3A). We conclude, therefore, that DLC-1 
affects the proliferative fate decision in the context of the motor complex, although it 
is unique among the light chains in doing so. 
 
The dynein motor complex promotes normal localization and levels of METT-10 
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Similarly to dlc-1, loss of METT-10 also enhances germ cell proliferation and 
formation of germ line tumors in the glp-1(oz264gf) sensitized genetic background 
(Chapter 2).  METT-10 accumulates in nuclei as cells enter meiosis, in line with its 
functions in inhibiting proliferative fate and promoting meiotic development (Figure 
4A).  Our finding that DLC-1 depletion enhances the glp-1(oz264gf) tumorous 
phenotype, coupled with the established role of dynein in trafficking proteins to the 
nucleus (Karki and Holzbaur, 1999; Giannakakou et al., 2000; Moseley et al., 2007; 
O'Rourke et al., 2007), suggested that DLC-1 may inhibit germ cell proliferative fate 
through regulation of METT-10 nuclear accumulation. Using RNAi, we found that 
DLC-1 knockdown decreases accumulation of a METT-10::GFP fusion protein in the 
nucleus throughout the germ line, and also in somatic cells (Figure 4A-B, data not 
shown).  
To confirm that DLC-1 functions with the motor complex to promote METT-
10 nuclear accumulation, we tested whether reductions in DHC-1 activity also 
resulted in a decrease in nuclear METT-10. We found that in a genetic background 
with decreased DHC-1 function [dhc-1(or195)] (Schmidt et al., 2005), METT-
10::GFP nuclear accumulation is delayed, with a strong nuclear signal only in late 
pachytene, rather than near transition zone as occurs in wild-type germ lines, in more 
than 50% of germ lines (Figure 4C).  This finding indicates that the dynein motor 
complex promotes METT-10 nuclear accumulation. 
 In addition to diminished nuclear localization, overall staining intensity for 
METT-10::GFP is reduced upon DLC-1 depletion, suggesting that DLC-1 also 
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promotes or maintains the total METT-10 protein level  (Figure 4B).  Indeed, 
immunoprecipitation of METT-10::GFP from animals treated with control RNAi or 
RNAi against dlc-1, revealed that total METT-10::GFP levels are reduced by DLC-1 
depletion (Figure 4D).   This reduction does not reflect a decrease in germ line size, 
because the levels of a ubiquitous germ line protein, CGH-1, were unchanged (Figure 
4D).  
 
DLC-1 regulates mett-10 RNA levels  
We considered two potential mechanisms by which DLC-1 could regulate 
total METT-10 protein accumulation. LC8-type dynein light chains regulate 
transcription (Rayala et al., 2005; Rayala et al., 2006), and interact directly with 
various proteins to regulate their subcellular localization and/or dimerization status, 
which could alternatively affect protein stability (Schnorrer et al., 2000; Day et al., 
2004; Navarro et al., 2004; Barbar, 2008).  To address whether DLC-1 regulates 
METT-10 at the RNA level, we tested the effect of DLC-1 depletion on levels of 
METT-10 mRNA using quantitative RT-PCR, and found that knockdown of DLC-1 
results in a 4 to 5-fold reduction in mett-10 mRNA relative to the germ line 
ubiquitous gene, cgh-1 (Figure 4E).  Thus, DLC-1 promotes overall METT-10 RNA 
levels, potentially through a transcriptional mechanism. 
 
DLC-1 binds METT-10 in vitro 
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We tested if DLC-1 directly interacts with METT-10 using GST pulldown 
affinity chromatography, and found that 6XHis-tagged METT-10 binds GST-DLC-1, 
but not other dynein light chains that show no effect on proliferative fate specification 
(Figure 5A).  We used a series of amino acid substitutions mutations in DLC-1 to see 
if its interaction with METT-10 requires the same amino acid domain shown to 
mediate LC8-type dynein light chain interaction with potential “cargo” proteins and 
dynein intermediate chain (Navarro et al., 2004). Indeed, disruption of amino acid 
residues F62, T67, and F73 in this motif greatly reduced binding to METT-10, while 
mutation of H68 did not (Figure 5B), showing that the interaction between DLC-1 
and METT-10 is similar to previously characterized interactions (Day et al., 2004). 
In the course of analyzing the physical interaction between METT-10 and 
DLC-1, we discovered that METT-10 strongly interacts with itself. We noticed an 
SDS-stable supershifted band in the gel electrophoresis of some METT-10 proteins 
equivalent to the expected size of a dimer (Figure 6A), in line with previous reports 
that some methyltransferases require multimerization for function (Mallam and 
Jackson, 2007; Tomikawa et al., 2008).  The stable self-interaction domain of METT-
10 maps to the C-terminal region (aa 272-479), and a supershift was never seen with a 
METT-10 N-terminal fragment that mimics the METT-10(oz36) truncation mutant 
(aa 1- 271) alone (Figure 6A). To confirm that METT-10 binds to itself, we carried 
out GST pulldown analysis between various METT-10 fragments and discovered that 
while the METT-10(oz36) truncated protein does not exhibit the SDS-stable self-
interaction, it binds to both itself and to the METT-10 C-terminus in GST-pulldown 
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analysis (Figure 6B).  We also observed the supershifted band for 6XHIS-tagged 
METT-10 proteins pulled down by GST-tagged METT-10 (Figure 5C, 6B), 
suggesting that METT-10 may exist in an oligomeric form. Interestingly, the putative 
METT-10 dimer is pulled-down by DLC-1, indicating that the C-terminal interface by 
which METT-10 interacts with itself is independent of the interface used to bind 
DLC-1 (Figure 5C).  
 
DLC-1 and the METT-10 nuclear localization signal (NLS) act redundantly to 
ensure METT-10 nuclear accumulation  
 The finding that DLC-1 interacts with METT-10 raised the possibility that 
DLC-1 directly participates in METT-10 nuclear accumulation.  Although the two 
proteins did not colocalize in vivo (Figure 7), it is possible that a transient interaction 
is sufficient to mediate the effect of DLC-1 on METT-10 localization. To address 
whether DLC-1 promotes METT-10 localization through direct binding, we needed to 
specifically test the contribution of DLC-1-interaction to METT-10 nuclear 
accumulation in vivo.  To this end, we mapped the residues in METT-10 that interact 
with DLC-1. Previous work showed that LC8-type light chains interact with a short 
peptide sequence in their target proteins, usually conforming to either a (S/K)XTQT 
or GIQVD sequence motif (Benison et al., 2007; Barbar, 2008), but METT-10 does 
not have either of these motifs.  We thus tested a series of METT-10 C-terminal 
truncations (data not shown), followed by individual amino acid replacements in an 
eight amino acid region for their ability to interact with DLC-1 in GST pulldown 
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experiments.  Mutation of METT-10 amino acid residues D420, N421, S423, and 
Q424 to alanine severely compromised binding to DLC-1, thus defining the METT-
10 motif that interacts with DLC-1 as “DNASQ” (Figure 5D). 
To determine the effect of DLC-1-binding on METT-10 localization in vivo, 
we constructed a transgenic version of METT-10::GFP in which the “DNASQ” motif 
was mutated to “AAAAA” (5A mutant, Figure 8A), and compared the localization of 
METT-10::GFP constructs within gonadal sheath cells, which are large cells that 
express METT-10 at high levels and thus are easy to visualize.  Wild type METT-
10::GFP is concentrated in the nucleus (Figure 4A, 8B), and disruption of the 
DNASQ motif that interacts with DLC-1 reduces, but does not eliminate, nuclear 
METT-10::GFP (Figures 4F, 8C).  
In addition to the DLC-1 binding motif, METT-10 also contains a potential 
nuclear localization sequence (ARKRAKA), raising the possibility that this may act 
redundantly with the DLC-1 binding site to enable METT-10 nuclear accumulation. 
Supporting this idea, deletion of the putative METT-10 nuclear localization signal 
(NLS) alone does not block nuclear entry (Figure 7D), but simultaneous disruption of 
both the NLS and the DLC-1 binding site makes METT-10 predominantly 
cytoplasmic (Figure 8E).   
 
Cytoplasmic METT-10 rescues most mett-10 mutant phenotypes 
Identification of at least two pathways promoting METT-10 nuclear 
accumulation enabled us to address if METT-10 nuclear accumulation is essential in 
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vivo, and whether the METT-10:DLC-1 physical interaction is vital to METT-10 
function.  To this end, we compared the abilities of the integrated transgenes 
expressing various mutant forms of METT-10 to rescue mett-10 mutant phenotypes. 
These included METT-10 with a mutant DLC-1 binding site (mett-10(5A)::gfp), a 
mutant DLC-1 binding motif and deletion of the NLS (mett-10(-NLS, 5A)::gfp), and 
METT-10 with a mutant DLC-1 binding site and a mutation in the catalytic core that 
should reduce the methyltransferase activity (mett-10(G110R,5A)::gfp) (see 
Methods). We compared expression of RNA and protein by the various transgenes 
using qRT-PCR and western blots (Figure 9, Methods). The RNA and protein levels 
of wild type and mutant transgenes are similarly correlated, agreeing with the finding 
described above that DLC-1 promotes METT-10 levels primarily by regulating mett-
10 RNA levels. 
Each mett-10 transgene was tested for its ability to suppress several mett-10 
mutant phenotypes, including abnormalities in somatic and germ cell development 
observed in the mett-10 null background, defective proliferative fate specification 
caused by loss-of-function mett-10 mutations, and germ line RNAi resistance 
(Chapter 2). 
 Loss of mett-10 function causes protrusion of the vulva, irregular gonadal 
shape, and defects in germ cell development leading to a sterile phenotype when 
animals are raised at 25˚C (Chapter 2).  While a methyltransferase-defective 
transgene failed to suppress any defects, mett-10(5A)::gfp and mett-10(-NLS, 5A)::gfp 
transgenes fully suppressed the protruding vulva phenotype and partially suppressed 
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abnormalities in gonad shape and germ cell development (Table 2A).   This partial 
suppression suggests that the degree of METT-10 nuclear accumulation, promoted by 
both DLC-1-interaction and the NLS, facilitates METT-10 functions, but is not 
essential.  Moreover, even in the absence of both the DLC-1 interaction site and the 
NLS, some residual METT-10 may still enter the nucleus (some nuclear puncta can 
be seen for mett-10(-NLS;5A)::gfp,  Figure 8E), causing partial suppression. The fact 
that methyltransferase-defective transgene does not rescue any of these phenotypes 
demonstrates that that enzymatic activity is required for METT-10 function, and it is 
possible that even if the critical METT-10 targets are nuclear proteins, METT-10 may 
also modify them in the cytoplasm before they enter the nucleus. 
Loss of mett-10 function compromises the balance between germ cell 
proliferation and differentiation that, similarly to dlc-1 and dhc-1, are revealed in a 
glp-1 hyperactivation mutant background (Chapter 2).  Thus, to evaluate the role of 
METT-10 nuclear accumulation in proliferative fate specification, we tested for 
rescue of the tumorous phenotype of glp-1(oz264gf) mett-10(g38) double mutants. 
Expression of METT-10(5A)::GFP  and METT-10(-NLS,5A)::GFP rescued the 
tumorous phenotype of glp-1(oz264) mett-10(g38) animals, but a methyltransferase-
defective version of METT-10 did not (Table 2B).  Thus, METT-10 inhibition of 
proliferative fate, similarly to other METT-10 developmental functions, requires 
enzymatic activity, but not the full extent of nuclear accumulation that is mediated by 
its NLS and DLC-1. 
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 Mutation of mett-10 causes germ line RNAi resistance.  To assess whether the 
mutant transgenes rescue the RNAi pathway defect of mett-10 mutants, we asked 
whether expression of METT-10(5A)::GFP or METT-10(-NLS;5A)::GFP could 
restore mett-10(ok2204) susceptibility to dsRNA directed against the germ line gene, 
gld-1.  We found that, similarly to other mett-10 phenotypes, expression of the mutant 
proteins could at least partially rescue RNAi resistance (Figure 10). 
 
Cytoplasmic retention does not underlie the poisonous nature of METT-10(oz36) 
 The role of METT-10 in proliferative fate specification was initially revealed 
by the antimorphic mett-10(oz36) truncation mutant, which exhibits germ line tumors 
even in the presence of wild type glp-1 (Chapter 2).  The dose-dependence of the 
tumorigenic effect of METT-10(oz36) suggested that it is a “poisonous” protein that 
disrupts the function of at least one other unknown factor that normally inhibits 
proliferative fate (Chapter 2).  Interestingly, METT-10(oz36) lacks both an NLS and 
a DLC-1 binding site, and thus is predominantly cytoplasmic (Figure 8A,F), 
suggesting that this change in localization may contribute, in part, to its poisonous 
nature. 
We tested the hypothesis that cytoplasmic retention of METT-10(oz36) plays 
a causal role in tumor formation by testing our cytoplasmically-retained METT-10 
transgene (mett-10(-NLS,5A)::gfp) for the ability to suppress METT-10(oz36)-
induced tumors.  In addition, we tested whether driving METT-10(oz36) into the 
nucleus by fusing it to the SV40 NLS could also suppress the tumorous phenotype.  
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We found that expression of cytoplasmic METT-10 could completely suppress 
METT-10(oz36) overproliferation.  Moreover, the nuclear version of METT-
10(oz36), METT-10(oz36::SV40NLS)::GFP, enhanced the tumorous phenotype of 
METT-10(oz36) (Figure 8G, Table 2).  Together, these data reinforce the idea that 
METT-10(oz36) has a dose-dependent effect on tumor formation, and further suggest 
that this effect is independent of the cytoplasmic localization of the mutant protein.   
Interestingly, we also found that a methyltransferase-defective version of 
METT-10 could suppress METT-10(oz36) induced tumor formation, suggesting that 
METT-10(oz36) acts as a poison by binding to and interfering with the function of 
another protein and/or molecule; a methyltransferase-defective version of METT-10 
could compete with METT-10(oz36) for binding and relieve this effect.  
Alternatively, since METT-10(oz36) can bind full-length METT-10 (Figure 6B), a 
methyltransferase-defective METT-10 could bind METT-10(oz36) itself and 
neutralize its poisonous activity. 
 
Dynein regulates proliferative fate independently of METT-10 
 Based on the above observations, one possible explanation for the 
enhancement of glp-1(oz264gf) tumor formation by DLC-1 depletion is the reduced 
METT-10 accumulation caused by decreased mett-10 RNA, combined with decreased 
transport of METT-10 to the nucleus. However, genetic interactions between mett-10, 
dlc-1 and dhc-1 indicate that dynein also plays roles in proliferative fate specification 
independent of its effects on METT-10 protein accumulation. 
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RNAi knockdown of DLC-1 enhances tumor formation in the mett-10(oz36) 
genetic background (Table 3A). Two different weak loss-of-function heavy chain 
alleles, dhc-1(or195) (Schmidt et al., 2005) and dhc-1(js319) (Koushika et al., 2004; 
Schmidt et al., 2005), also specifically enhanced the mett-10(oz36) tumorous 
phenotype, although the dhc-1(js121) allele did not (Table 3B). Because METT-
10(oz36) cannot detectably interact directly with DLC-1, the ability of DLC-1 
knockdown and dhc-1 reduction-of-function mutants to further enhance tumor 
formation indicates that DLC-1 also regulates proliferative fate independently of its 
effects on METT-10.   
 
METT-10 and dynein may function together in multiple contexts 
 The dhc-1(js319) dynein heavy chain mutation did not cause tumors when 
combined with loss-of-function mett-10 alleles, but the double mutant animals had a 
fully penetrant sterility not seen in either mutant alone.  On closer examination, dhc-
1(js319); mett-10(-) germ lines exhibited two primary defects reminiscent of the 
phenotypes caused by RNAi knockdown of DLC-1: polyploidy in the distal region 
and unpaired chromosomes in diakinesis (Figure 11 and Table 4).  We also saw these 
phenotypes at low penetrance in dhc-1(js319) animals, but they are distinct from the 
cell cycle progression defects observed in mett-10 single mutants (Chapter 2).  Thus, 
loss of mett-10 function enhances a hypomorphic dhc-1 allele, causing phenotypes 
typical of dynein loss of function mutations. This indicates that METT-10 also 
facilitates the function of the dynein motor complex in cell division and meiosis. 
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Complete loss of mett-10 function alone does not cause these phenotypes, indicating 
that mett-10 function in cell division and meiotic events is not essential unless dynein 
function is partially compromised.  
Reduction in glp-1 activity suppresses germ line overproliferation, but not the 
polyploidy and unpaired chromosome phenotypes of dhc-1; mett-10(oz36) double 
mutants (Tables 3 & 4). Thus the roles of mett-10 and dynein in cell division and 
meiotic events can be separated from their roles in regulation of the proliferative fate 
decision. We conclude, therefore, that regulation of proliferative fate, perhaps through 
negative regulation of glp-1 signaling, is only one cellular function in which dynein 
and METT-10 cooperate. 
Interestingly, we also found that expression of a METT-10 protein unable to 
directly interact with DLC-1, METT-10(5A)::GFP, results in polyploidy in the distal 
region of the germ line, a phenotype reminiscent of loss of dlc-1 function (Figure 4F, 
compare with Figure 3C).  The penetrance of this phenotype correlated with the level 
of transgene expression and was suppressible by RNAi directed against GFP (data not 
shown).  This dominant phenotype suggests that METT-10(5A)::GFP acts as a 
dominant negative with respect to some dlc-1 functions, potentially through 
disruption of a complex made up of METT-10, DLC-1, and other proteins. 
 
dhc-1(js121), dhc-1(jor195), and dhc-1(js319) each affect a different functional 
domain of Dynein Heavy Chain-1 
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The differential genetic interactions between dynein heavy chain-1 and mett-
10 alleles with respect to proliferative fate specification, cell division, and meiotic 
pairing/recombination, may be due to the nature of the dhc-1 mutations, which affect 
different parts of the heavy chain locus (Figure 12).  The mutant with the strongest 
effect on tumor formation but no effect on the polyploidy/univalent phenotype, dhc-
1(or195), was previously shown to carry a missense mutation in the microtubule stalk 
domain (Figure 12 and O'Rourke et al., 2007), which mediates the interaction of the 
motor complex with microtubules and plays a key role in determining the direction of 
motility (Carter et al., 2008).  Sequencing of dhc-1(js319), which has strong genetic 
interactions with mett-10 affecting tumor formation, polyploidy, and chromosome 
pairing, reveals a AG>AA mutation in the splice acceptor for exon 13.  If we assume 
that this mutation results in exon skipping, this would result in a truncation C-
terminal to the 5th and 6th “ATP-ase-like” domains; this region has no known function.  
Finally, dhc-1(js121)  is predicted to have the most severe effect on dynein function, 
as it is an AG>>AA mutation in the splice acceptor for exon 6, which encodes the 
linker domain immediately preceeding the first ATPase domain (Figure 12).  The 
linker domain is thought to play an essential role in dynein motility (Burgess et al., 
2003).  Both dhc-1(or195) and dhc-1(js319) behave as temperature-sensitive, weak 
dynein heavy chain  alleles, especially at the permissive temperature of 20˚C and in 
the presence of maternal gene product.  On the other hand, dhc-1(js121), which is 
predicted to have the most severe effect on dynein function, behaves as a stronger 
loss-of-function [dhc-1(js121) homozygotes are sterile].  Thus, dhc-1(js121) may fail 
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to enhance mett-10(oz36) because of pleiotropic effects that mask any role in 
proliferative fate specification. 
 
 
DISCUSSION 
Dynein inhibits specification of proliferative fate in the C. elegans germ line 
The genetic and molecular studies presented here demonstrate that the dynein 
motor protein complex inhibits the decision of germ cells to proliferate in the C. 
elegans germ line, despite being necessary for the execution of mitotic cell division in 
those cells that do proliferate. The evidence further indicates that Dynein regulates 
this cell fate decision in part by promoting expression and function of the METT-10 
putative methyltransferase that inhibits proliferative fate, and in part through a 
METT-10-independent pathway.   
 
DLC-1 regulates METT-10 RNA levels and protein subcellular localization 
DLC-1 knockdown reduces both METT-10 RNA and protein levels. The 
mammalian LC8-type dynein light chain, DLC1, localizes to chromatin and acts in a 
transcriptional transactivation complex with estrogen receptor (Rayala et al., 2005), 
raising the possibility that DLC-1 could directly regulate mett-10 transcription. It is 
also possible that DLC-1 normally promotes mett-10 RNA stability, or enables the 
nuclear localization of other proteins that ensure adequate mett-10 transcription. 
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The direct physical interaction between DLC-1 and METT-10 reported here 
appears to play a redundant, non-essential role in METT-10 function. We showed that 
nuclear localization signal (NLS)-mediated and dynein-mediated pathways act 
redundantly to ensure normal METT-10 nuclear accumulation. The role of dynein and 
the microtubule network, and specifically LC8-type light chains, in facilitating the 
nuclear import of proteins is well documented (Giannakakou et al., 2000; Trostel et 
al., 2006; Moseley et al., 2007; Roth et al., 2007; Desfarges et al., 2009; Shrum et al., 
2009).  However, in cases where it has been examined, dynein mediates nuclear 
accumulation by enhancing the efficiency of NLS-dependent nuclear import 
(Moseley et al., 2007; Roth et al., 2007).  In these cases, unlike the example of 
METT-10, nuclear accumulation still requires an intact NLS.  Thus, our work reveals 
a qualitatively different role for dynein, and LC8/DLC-1 interaction, in mediating 
nuclear accumulation. We cannot rule out the possibility, however, that DLC-1 
specifically promotes the function of a secondary, non-canonical NLS in METT-10. 
When we specifically disrupted NLS- and DLC-1- mediated METT-10 
nuclear accumulation in vivo, we found that it plays a non-essential role in most mett-
10 developmental functions.  Because our double mutants still retain some residual 
nuclear METT-10, a small nuclear pool may be sufficient to carry out its function as a 
methyltransferase.  It is also possible that METT-10 association with dynein is 
transient, and promotes modification of target molecules on their way to the nucleus, 
with METT-10 nuclear accumulation as a byproduct.  In this scenario, cytoplasmic 
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METT-10 would be able to modify targets in the cytoplasm before their transport to 
the nucleus.   
While DLC-1 may inhibit proliferative fate in part through promotion of 
normal METT-10 activity, it is clear that DLC-1 (and dynein) inhibit proliferative 
fate by other means as well, since disruptions in dynein function enhance germ line 
tumor formation of the mett-10(oz36) cytoplasmic mutant. Interestingly, disruptions 
of dynein function do not cause germ line tumors in other mett-10 mutant 
backgrounds, including the null.  Since METT-10(oz36) is proposed to “poison” the 
function of another gene product through an unproductive physical association 
(Chapter 2), it is possible that dynein promotes the normal function of the gene 
product(s) poisoned by METT-10(oz36), thus sensitizing mett-10(oz36) to 
perturbations in dynein function.  Moreover, it is likely that METT-10, dynein, and 
this “poisoned factor” function to negatively regulate the pro-proliferative functions 
glp-1/Notch signaling, as the mett-10(oz36); dhc-1(or195) tumors are exquisitely 
sensitive to the levels of glp-1 activity. 
 
METT-10 and dynein function together in cell division and meiosis 
While METT-10 and the dynein motor complex function together to inhibit 
germ cell proliferative fate, we also uncovered a role for METT-10 in other dynein-
dependent processes. Specifically, decreases in METT-10 activity enhance the mitotic 
and meiotic defects of a weak dynein heavy chain loss-of-function allele, leading to 
highly penetrant sterility, polyploidy, and unpaired chromosomes in diakinesis. 
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Interestingly, O’Connell and colleagues identified a phenotype in mett-10(oj32) loss-
of-function mutants similar to those seen in dynein loss of function mutants 
(O'Connell et al., 1998). Specifically, mett-10(oj32) embryos have a visible defect in 
the flattening of the posterior centrosome during the first asymmetric division 
(O'Connell et al., 1998).  The function of centrosome flattening is unclear, but may be 
caused by the dynein-dependent force that pulls the posterior centrosome towards the 
posterior pole, thus ensuring asymmetric division (Severson and Bowerman, 2003; 
Nguyen-Ngoc et al., 2007). Importantly, defects in centrosome flattening are also 
observed for perturbations in dynein and dynactin function (Severson and Bowerman, 
2003; Schmidt et al., 2005; Couwenbergs et al., 2007).  Together these data suggest 
that METT-10, perhaps through its interaction with DLC-1, functions to promote 
multiple dynein-dependent events, although the mechanisms remain unclear.  
Moreover, if METT-10 and dynein jointly function in proliferative fate specification, 
cell division, and meiotic pairing and/or recombination, then the normal function of 
METT-10 in all these processes may be to promote dynein activity, which in turn 
promotes METT-10 function in a positive feedback loop. 
 
Proliferative and anti-proliferative roles of dynein 
The dynein motor complex participates in a diversity of processes, including 
nuclear movements, spindle assembly and orientation, mitotic checkpoint 
inactivation, organelle movement, and endocytosis (Henderson et al., 1994; Karki and 
Holzbaur, 1999).  Here we show that dynein inhibits the specification of germ cell 
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proliferative fate, despite also being necessary for mitotic cell division in proliferating 
cells.  These “anti-proliferative” (cell fate) and “pro-proliferative” (cell fate 
execution/cell division) functions of dynein are not unique to the maintenance of the 
balance between proliferation and differentiation in the C. elegans germ line. The 
essential roles of dynein in the execution of cell division are well known (Karki and 
Holzbaur, 1999), as is its role in promoting the activity of tumor suppressors, 
including p53, by facilitating their nuclear transport (Giannakakou et al., 2000; 
Fabbro and Henderson, 2003; Trostel et al., 2006; Roth et al., 2007).  Moreover, in 
keeping with its many cellular functions, the dynein motor complex influences 
multiple cell fate decisions by a diversity of mechanisms.  These include the 
trafficking of cell fate determinants, such as egalitarian and its associated oskar 
mRNA (Navarro et al., 2004), spindle positioning during asymmetric division 
(Couwenbergs et al., 2007), ensuring the normal timing of mitotic cell division (Fan 
and Ready, 1997), and now by promoting RNA levels and protein nuclear 
accumulation of a factor influencing cell fate.  Thus dynein acts as a “handyman”, 
performing many of the jobs necessary to execute a developmental program. 
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MATERIALS AND METHODS 
General worm culture and genetics 
 Standard procedures for culture and genetic manipulation of C. elegans strains 
were followed (Brenner, 1974). Strain constructions were verified by single worm 
PCR and sequencing of alleles.  
Alleles used in this study by chromosome: 
I: rrf-1(pk1417), dhc-1(js319), dhc-1(or195), dhc-1(js121) 
III: mett-10(oz36)[antimorph], mett-10(g38) [hypomorph], mett-10(tm2697) 
[hypomorph], mett-10(oj32)[hypomorph], mett-10(ok2204)[null], glp-1(oz264gf), glp-
1(bn18ts) 
Integrated Transgenes: 
ozIs7[pmett-10:mett-10::gfp; unc-119(+)]  
ozIs9[pmett-10:mett-10(5A)::gfp; unc-119(+)] (LOW)  
ozIs11[pmett-10:mett-10(5A)::gfp; unc-119(+)] (HIGH)  
ozIs15[pmett-10:mett-10(oj32,5A)::gfp; unc-119(+)] (line1) 
ozIs16[pmett-10:mett-10(oj32,5A)::gfp; unc-119(+)] (line2)  
ozIs20[pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)](line 1) 
ozIs21[pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)](line 2) 
ozIs19 [pmett-10::mett-10(oz36)::gfp; unc-119(+)] 
ozIs25[pmett-10::mett-10(oz36::SV40NLS)::gfp; unc-119(+)] 
Extrachromosomal arrays: 
ozEx66 [pmett-10:mett-10::gfp; unc-119(+)] 
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ozEx69 [pmett-10:mett-10(-NLS)::gfp; unc-119(+)] 
ozEx67 [pmett-10:mett-10(5A)::gfp; unc-119(+)] 
ozEx72 [pmett-10:mett-10(-NLS, 5A)::gfp; unc-119(+)] 
ozEx73 [pmett-10:mett-10(oz36)::gfp; unc-119(+)] 
ozEx74[[pmett-10:mett-10(oz36::SV40NLS)::gfp; unc-119(+); pmyo-2::mcherry] 
 
Sequencing of dhc-1 alleles 
To sequence the entirety of the dhc-1 locus, including introns and exons, 
primers amplifying 1kb regions and containing 200 bp overlap on either side were 
used to amplify fragments that spanned the entire dhc-1 locus, including 
approximately 200bp upstream and downstream of transcriptional start and stop, and 
all introns from the dhc-1(js319) and dhc-1(js121) mutants.  These were then cleaned 
and sequenced, assembled using SeqMan (DNAstar), and aligned to the N2 dhc-1 
sequence from wormbase to identify mutations. 
 
Immunohistochemistry 
Germ line dissection, fixation, and staining was carried out as previously described 
(Lee et al., 2007).  Antibodies used were: monoclonal mouse ant-GFP (mAb3E6) 
from Invitrogen (Cat# A-11120) at 1/100, Rabbit anti-DLC-1 at 1/10 (see below) and 
donkey anti-mouse Alexa 594, goat anti-rabbit Alexa 488, goat anti-rabbit Alexa 594 
at 1/400, obtained from Molecular Probes (Invitrogen, CA). EdU labeling and co-
staining with antibodies was carried out as described in (Chapter 2). 
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Generation of anti-DLC-1 antibody and quantification of DLC-1 levels 
To generate the GST:DLC-1 fusion protein, full length DLC-1  was cloned 
into the pGEX-5x-3 vector (GE Healthcare Life Sciences, Cat# 27-4586-01).  
Inductions were carried out in the E. coli strain BL21(DE3) (Sigma, MO).  From an 
overnight starter culture grown at 30˚C, cultures were diluted and grown at 37˚C until 
they reached an OD of 0.5.  Cells were induced with 1mM IPTG for 3 hours at 37˚C.  
Cells were harvested and GST-DLC-1 was then extracted essentially as described in 
(Sambrook and Russell, 2001) and injected into rabbits by Pocono Rabbit Farm & 
Laboratory (Canadensis, PA).  Sera were affinity purified against a 6XHIS:DLC-1 
fusion protein.  To make 6XHIS:DLC-1, DLC-1 was amplified from pGEX (DLC-1), 
and cloned into pTRCHIS (Invitrogen, Cat # K4410-01, K4410-40).  
pTRCHIS(DLC-1) was transformed into BL21(DE3) cells, and cultures were induced 
similarly to GST-DLC-1.  6XHIS-DLC-1 was extracted under native conditions using 
Ni-NTA agarose (Qiagen, Cat# 30210).  6XHIS-DLC-1 was subsequently coupled to 
Cyanogen-Bromide activated Sepharose (Sigma, MO, Cat# C9142) and antibody 
purification was carried out essentially as previously described (Jones et al., 1996).  
Specificity was determined both by Western (where antibody recognizes a single 
10kDa band) and by antibody staining of germ lines and intestines from animals 
treated with and without dlc-1 RNAi.  
 For quantification of DLC-1 levels (in Figure 2J), raw images of DLC-1 
staining were imported into Image J, germ lines were traced, and average pixel 
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intensity was calculated.  All pixel intensities were then normalized to represent % 
knockdown by dividing the pixel intensity for the sample by the average DLC-1 pixel 
intensity for glp-1(oz264) germ lines fed control RNAi and multiplying by 100. 
 
Image capture and processing 
Fluorescence micrographs were taken on a Zeiss compound microscope using 
AxioPlan 2.0 imaging software and Hamamatsu camera. Each dissected and stained 
gonad was captured as a montage, with overlapping cell boundaries. The montages 
were then assembled in Adobe Photoshop CS3 and processed identically. The 
boundary of each montage was processed using a feather tool of 20 pixels for each 
image.  Confocal images were captured on a Perkin Elmer Ultraview Confocal 
Microscope using a z-step of 0.3 microns. 
 
RNAi screen of METT-10 interactors 
 RNAi clones were either purchased from Open Biosystems or generated by 
PCR amplification and cloning of 1kb exonic sequences into the pPD128.36 double 
T7 promoter vector, sequenced to verify identity, and transformed into the E. coli host 
HT115(DE3).  Feeding RNAi was performed as previously described (Lee et al., 
2007), in  rrf-1(pk1417),  rrf-1(pk1417); glp-1(oz264gf), and rrf-1(pk1417); mett-
10(oz36) backgrounds at the permissive temperature (20oC). F1 L4 hermaphrodites 
were transferred onto fresh RNAi plates and scored quantitatively for germ line 
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tumors 48 hrs later by DIC microscopy.  In the course of the screen, it came to our 
attention that mett-10 mutants are relatively resistant to germ line RNAi. 
 
Construction of transgenes and generation of transgenics 
 The initial mett-10::gfp construct includes 1.6 kb upstream and 1.9 kb 
downstream of the METT-10 coding region with GFP(ivs):FLAG inserted 
immediately before the translational stop cloned into the pMM016 vector containing 
the transformation marker, unc-119(+) (Chapter 2).  Mutations of the mett-10 coding 
region, including NLS deletion, DNASQ>AAAAA, methyltransferase-mutation 
(G110R), and deletion of coding sequences downstream to the mett-10(oz36) 
premature stop codon, were done with sewing PCR (Lee and Schedl, 2001).  To 
create mett-10(oz36::SV40NLS)::gfp, the sequence 
“CAAAATCGTCTGCCAAAGAAGAAGCGTAAGGTA” encoding the SV40NLS 
was inserted immediately prior to GFP using sewing PCR and the mett-10(oz36)::gfp 
construct as a template. To create low-copy integrated transgenic lines, the 
microparticle bombardment method was used (Praitis et al., 2001).  Generation of 
extrachromosomal arrays was done by injection pMM016(mett-10) plasmids at a 
concentration of 40ng/ul into unc-119(ed3) worms. 
 
GST-pulldowns 
 Full length METT-10 (C. elegans coding region ZK1128.2a), METT-
10(oz36) (aa 1-271), or METT-10(Cterm) (aa 272-479) were amplified from N2 
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Bristol cDNA and cloned into pTRCHIS (Invitrogen, Cat # K4410-01, K4410-40), 
sequenced, and transformed into BL21(DE3)  (Sigma, MO) cells for expression.  
Proteins were expressed under the same conditions as GST-DLC-1 (above).  For GST 
pulldowns, bacterial extracts were resuspended in PBS + protease inhibitors and 
sonicated.  Cleared cell extracts were added directly to 5ug of GST-DLC-1 already 
bound to Glutathione-sepharose in 20mM Tris pH 7.5, 500mM NaCl, 0.5% NP40, 
and 1X protease inhibitors.  Binding reactions were carried out overnight at 4˚C, 
washed 4X with 10mM Tris pH 7.5, 150mM NaCl, and 0.1% NP40.  Western blot 
analysis using an anti-6XHIS antibody (Amersham Biosciences, Cat# 27-4710-01) 
was performed from beads boiled in SDS-sample buffer with BME.  Point mutations 
in METT-10 and DLC-1 were generated using sewing PCR or site-directed 
mutagenesis. 
 
Immunoprecipitation and Western Analysis 
 To generate enough worms for IP-Western of METT-10:GFP (flag), we 
resuspended worms from ten 60mm overgrown plates of each transgenic line in 5% 
lactose and 10X OP50 or 1X bacterial expressing dsRNA and plated these onto ten 
100mm plates, which were shifted to 25˚C to maximize transgene expression.  After 
two days, worms were washed off in PBS and extracts and IPs were carried out 
essentially as described in (Guang et al., 2008).  Immunoprecipitated proteins were 
analyzed using Western blots with both mouse monoclonal anti-FLAG M2 (Sigma, 
Cat# F1804) and Rabbit anti-GFP (Invitrogen, Cat#A11122) antibodies.  For loading 
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controls, we used mouse anti-alpha-tubulin (Sigma, Cat#T9026) and anti-CGH-1 (gift 
of David Greenstein). 
 
RNA quantification 
 To measure mett-10:gfp transgene expression relative to endogenous, each 
mett-10::gfp transgene was crossed into the mett-10(ok2204) background, which 
contains a large deletion of the mett-10  5’ region. Total RNA was isolated using 
Trizol (Invitrogen), treated with DNase I (Epicentre), chloroform extracted, ethanol 
precipitated and dissolved in water. cDNA was synthesized using random hexamer 
primers and SuperScript VILO reverse transcriptase (Invitrogen). Transcripts were 
quantified using Sybr green real-time PCR (Clontech) and gene-specific primers (see 
below) calibrated with genomic DNA. RNA levels were calculated adjusting for 
amplification efficiency (Pfaffl, 2001) and normalizing to internal cgh-1 or act-3 
transcripts and external genomic DNA standards. Standard deviations were calculated 
using all PCR replicates from all biological replicates. 
Primers used for quantitative RT-PCR:  
Gene           Forward Primer                            Reverse Primer   
mett-10  TGATATTGGCACCGGAACATCGTG  CATCTCCGTCAGTGGCAATGAACT 
dlc-1  TGGCATTGCATCGTCGGAAGAAAC AGACTTGAATAGCAGGATGGCGAC 
act-3      TCTTGACTTGGCTGGACGTGATCT    TGATGTCACGGACGATTTCACGCT 
cgh-1     ATCAACTTCCTCCCAAAGGAGCG TCATACGGCTTGTGCATGTGCTTC 
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Table 1: An RNAi screen of METT-10 yeast two-hybrid interactors reveals 
multiple inhibitors of proliferative fate 
gene name COSMID 
%Tum                                    
(rrf-1(pk1417);      
glp-1(oz264) (n) 
%Tum                                   
GFP(RNAi) 
control (n) 
two-
tailed    
p-value 
     
  R07B7.2 16.9(130) 14.6(96) 0.71 
dlc-1 T26A5.9 87.5(88) 11.8(76) <0.0001* 
     
pqn-59 R119.4 58.8(216) 14.9(262) <0.0001* 
plk-1 C14B9.4 22.5(80) 26.9 (26) 0.79 
vab-3# F14F3.1 7.9(68) 13.8(50) 0.26 
eya-1# C49A1.4 18.8(154) 12.3(138) 0.15 
     
npp-9 F59A2.1 16.7(66) 10.0 (70) 0.31 
mpk-1 F43C1.2 0(70) 18(50) 0.0002** 
pmk-1 B0218.3 12.8 (86) 11.8 (76) 1 
 W03D8.3 6.8(88) 9.6 (94) 0.59 
ran-1 K01G5.4 6.9(58) 20.8(96) 0.02** 
     
hrd-1 F55A11.3 51.6(192) 16.7(192) <0.0001* 
scrm-8 K08D10.7 9.7(72) 9.6(94) 1 
cks-1 C09G4.3 25.0 (144) 13.1(130) 0.006* 
tag-332 Y119C1B.8 62.5(152) 12.3(154) <0.0001* 
All genes are organized by "interactome" branch, with the first row after each division 
occupied by the gene predicted to be a primary interactor of METT-10.                               
#vab-3 and eya-1 are found in two separate interactome branches, and are predicted to 
directly interact with both pqn-59 and npp-9.                                                                         
*RNAi treatments that led to significant enhancement of the glp-1(oz264) tumorous 
phenotype.                                                                                                                             
**RNAi treatments that significantly suppressed glp-1(oz264) overproliferation. All animals 
were scored at 2 days past the L4 stage at 20˚C.  p-values were calculated by Fisher's exact 
test, using simultaneous GFP RNAi treatments to calculate expected values. 
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Table 2 : transgenic rescue of mett-10 phenotypes 
    
  mett-10(ok2204) @ 25˚C 
A.                         transgene % Pvl % Ste n 
% abnormal gonad 
shape (n)* 
no transgene 98 99 82 30(44) 
met-10(wt)::gfp 5 0 38 0(35) 
mett-10(5A)::gfp  LOW 65 19** 43 n.d. 
mett-10(5A)::gfp  HIGH 1 0 137 3(32)** 
mett-10 (enzymatic-
defective,5A)::gfp, line 1 92 98 46 30(43) 
mett-10 (enzymatic-
defective,5A)::gfp, line 2 97 99 97 n.d. 
mett-10(-NLS,5A)::gfp line 1 0 19 42 10(31)** 
mett-10(-NLS,5A)::gfp line 2 0 14 36 12(25) 
*gonads with one or more ectopic distal protrusions.                                                       
**two-tailed p-value, Fisher's exact test < .05                                            
   Pvl = protruding vulva, Ste = sterile                       
  
  
     
B. % Tumorous germ lines (n)  
transgene 
mett-
10(ok2204) 
(m-z-, 15˚C) 
mett-10(oz36) 
(m+z-, 20˚C) 
glp-1(oz264) 
mett-10(g38) 
(m+z-)  
no transgene 0(96) 41(66) 89(47)  
met-10(wt)::gfp 0(136) 0(80) 0(56)  
mett-10(5A)::gfp  LOW 0(86) 0(86) 0(54)  
mett-10(5A)::gfp  HIGH 0(36) n.d. n.d.  
mett-10 (enzymatic-
defective,5A)::gfp, line 1 0(36) n.d. 91(84)  
mett-10 (enzymatic-
defective,5A)::gfp, line 2 0(48) 2(107) 94(83)  
mett-10(-NLS, 5A)::gfp, line 1 0(37) 0 (128) 4.3 (94)  
mett-10(oz36)::gfp n.d. 94(90) n.d.  
mett-10(oz36:SV40NLS)::gfp n.d. 97(74) n.d.  
 
 
 
 
 128 
Table 3: compromising dynein function enhances the 
tumorous phenotype of the mett-10(oz36) mutant 
genotype %Tum n 
A. dlc-1#     
rrf-1(pk1417); mett-10(oz36); gfp(RNAi) 3 117 
rrf-1(pk1417); dlc-1(RNAi) 0 122 
rrf-1(pk1417); mett-10(oz36); dlc-1(RNAi) 62 130 
   
B. dynein heavy chain$     
dhc-1(or195) 0 37 
mett-10(oz36) 43 65 
dhc-1(or195); glp-1(oz264) 9 22 
dhc-1(or195); mett-10(tm2697) 0 35 
dhc-1(or195); mett-10(g38) 0 18 
dhc-1(or195); mett-10(oj32) 0 26 
dhc-1(or195); mett-10(ok2204) 0 65 
dhc-1(or195); mett-10(oz36) 100** 46 
dhc-1(or195); glp-1(bn18) mett-10(oz36) 0 38 
dhc-1(js319) 0 26 
dhc-1(js319); glp-1(oz264) 6 17 
dhc-1(js319); mett-10(tm2697) 0 59 
dhc-1(js319); mett-10(g38) 0 40 
dhc-1(js319); mett-10(oj32) 0 30 
dhc-1(js319); mett-10(ok2204) 0 24 
dhc-1(js319); mett-10(oz36) 76** 42 
dhc-1(js319); glp-1(bn18) mett-10(oz36) 0 52 
dhc-1(js121); mett-10(oz36) 3 35 
# Animals were m-z-, i.e. came from homozygous mutant 
mothers. The  rrf-1(pk1417) enables germ line restricted RNAi.  
All RNAi and scoring was carried out at 20˚C. 
$All animals were m+, i.e. came from mothers carrying a wild 
type copy of mett-10 and were scored at 2 days past L4 at 20˚C 
by dissection and DAPI staining.               
 ** indicates significance calculated by Fisher's exact test, using 
mett-10(oz36) alone for expected values. 
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Table 4: mett-10 loss-of-function alleles enhance mitotic and meiotic defects 
of a dhc-1 allele. 
 % Germ lines  
genotype 
 with polyploid 
nuclei 
with univalents 
in diakinesis n 
dhc-1(js319) 4 4 26 
dhc-1(js319); glp-1(oz264) 5 0 19 
dhc-1(js319); mett-10(tm2697) 100 42 59 
dhc-1(js319); mett-10(g38) 100 30 40 
dhc-1(js319); mett-10(ok2204) 92 8 24 
dhc-1(js319); mett-10(oj32) 97 3 30 
dhc-1(js319); mett-10(oz36) 100 - 42 
dhc-1(js319); glp-1(bn18) mett-10(oz36) 100 12 52 
 
 
 
Polyploid nuclei are large and DAPI dense. These are distinct from the enlarged, 
diffusely staining nuclei indicative of cell cycle arrest observed in mett-10(-) mutants. 
 
All animals were m+, i.e. came from mothers carrying a wild type copy of mett-10 and 
were scored at 2 days past L4.                
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Figure 1. Organization of the C. elegans germ line. (A) A fluorescence micrograph 
of a dissected, DAPI-stained adult C. elegans hermaphrodite germ line with 
schematic. In the distal region proliferating germ cells (2) reside in close contact with 
the somatic distal tip cell (1).  At the transition zone (3), germ cells enter meiosis, and 
proceed through meiotic prophase (4) to give rise to sperm (6) and oocytes (5).  (B) 
Scheme depicting the decision that C. elegans germ line stem cells have to make 
between maintaining a proliferative fate (green) versus differentiation (red), to 
produce gametes.  
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Figure 2. Schematic of yeast two-hybrid interactome for METT-10. Each 
individual line indicates a direct interaction identified in a genome-wide yeast two-
hybrid screen (Li et al., 2004).  Ovals represent an individual gene.  Shaded ovals 
represent genes whose disruption by either mutation RNAi enhances glp-1(oz264gf) 
overproliferation. 
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Figure 3. dlc-1 inhibits proliferative fate in the C. elegans germ line. (A) RNAi 
against dlc-1 and dhc-1 enhances tumor formation in the glp-1(oz264gf) background 
at 20˚C, while RNAi against other light chains does not; dlc-2: paralog of dlc-1; dylt-
1: Tctex-type dynein light chain; dyrb-1: Roadblock-type light chain. Two-tailed p-
values determined using Fisher’s Exact Test.  In wild type germ lines (B) as well as in 
dlc-1 RNAi of control animals (C), a 3 hr pulse of the nucleotide analog EdU, which 
incorporates during DNA synthesis, labels (green) only the very distal end (left) of 
the germ line, although dlc-1 RNAi causes polyploid nuclei containing large, dense 
DNA bodies (white arrow) and unpaired chromosomes in diakinesis. Insets show 
chromosomal morphology of diakinetic oocytes, with 6 sets of bivalents in oocytes 
from control germ lines (B), but 12 univalents for dlc-1 RNAi (C).  (D-E) dlc-1 RNAi 
causes tumor formation and EdU incorporation throughout the germ line in glp-
1(oz264gf) (E), while glp-1(oz264gf) mutant on its own has only a marginal increase 
in EdU-incorporation (D).  (F-H) Staining against DLC-1 in glp-1(oz264gf) animals 
treated with dsRNA targeting either gfp as a control (F) or dlc-1 (G-H).  (G) a 
tumorous germ line with partial DLC-1 knockdown and unaffected nuclear 
morphology and (H) a tumorous germ line with strong DLC-1 knockdown and 
abnormal nuclear morphology. (I) Inset from (H) highlights the large size of 
abnormal nuclei. Solid arrows indicate large, DNA dense (abnormal) nuclei, and 
feather arrows indicate nuclei of relatively normal size. (J) Quantification of DLC-1 
levels by pixel intensity for glp-1(oz264gf); gfp(RNAi) germ lines (white bar), glp-
1(oz264gf);dlc-1(RNAi) tumorous germ lines with normal nuclear morphology (black 
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bar), and glp-1(oz264gf);dlc-1(RNAi) tumorous germ lines with abnormal nuclear 
morphology (grey bar).  Error bars indicate the SEM.  All scale bars = 20 microns.  
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Figure 4.  DLC-1 promotes METT-10 nuclear accumulation. (A) METT-10::GFP 
expression in a wild type germ line. (B)  dlc-1 RNAi causes a decrease in METT-
10::GFP accumulation, abnormal nuclear morphology (left panel),  and unpaired 
chromosomes in diakinesis (right panel, yellow arrows). (C) METT-10::GFP nuclear 
accumulation is delayed in the dhc-1(or195) mutant background, with nuclear 
accumulation observed only in late pachytene.  Solid and feather arrows indicate 
nuclei positive and negative for METT-10::GFP, respectively (D) IP-westerns for 
METT-10:GFP levels in whole animals subject to both control (empty vector) RNAi 
as well as dlc-1(RNAi). CGH-1 is a germ line ubiquitous protein. (E) qRT-PCR for 
dlc-1 and mett-10 normalized to cgh-1 mRNA levels.  RNAi was carried out in the 
rrf-1(pk1417) background, which retains RNAi only in the germ line. (F) METT-
10(5A)::GFP protein is reduced in germ line nuclei, although some nuclear METT-10 
(5A):GFP is observed in nuclei of the somatic gonad (see circled sheath cell nucleus).  
At variable penetrance, abnormal, DNA-dense nuclei similar to those observed for 
dlc-1 (RNAi) are seen at the distal end.  Germ line shown is more severe than most. 
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Figure 5. METT-10 binds DLC-1 in vitro. (A) Full length 6X-HIS METT-10 is 
pulled down by GST-DLC-1, weakly pulled down by GST-DLC-2, and not by GST-
DYLT-1 or GST-DYRB-1. (B) GST-DLC-1 point mutants (Coomassie) were assayed 
for binding to full length 6XHIS-METT-10 proteins. (C) A dimeric band  (feathered 
arrow) is observed when full length 6X-HIS-METT-10 is pulled down with GST-
DLC-1 and full length GST-METT-10. (D) Fine mapping of the DLC-1 binding 
domain of METT-10 using GST-pulldown analysis analogous to that shown in (A).  
The identity of individually-mutated METT-10 residues are labeled on the left.  
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Figure 6.   METT-10 can form multimers. (A) Western blot analysis on bacterially 
expressed 6XHIS-METT-10 fusion proteins reveals bands that run at the size of 
monomers (*) and dimers ($).  (B) GST pulldown analysis between METT-10 protein 
fragments. The C-terminal METT-10 protein fragment (aa 272-479) binds full length 
and METT-10(oz36) (aa 1-271) protein fragments (gel on left).  Feathered arrow 
indicates that 6XHIS-METT-10(C-term) runs at the size of a dimer. 6XHIS-METT-
10(oz36) protein fragment can bind a GST-tagged METT-10(oz36) fragment, but no 
dimeric band is observed (gel on right). 
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Figure 7. METT-10 and DLC-1 do not co-localize in vivo.  Scanning-Laser 
Confocal images of germ cells in meiotic pachytene co-stained with an antibodies 
against METT-10::GFP (green) DLC-1 (red), and DAPI to visualize DNA (blue).  (A) 
DLC-1 is a predominantly cytoplasmic protein, although some nuclear puncta are 
observed, agreeing with previous findings in mammalian cells (Rayala et al., 2005). 
(B) METT-10::GFP is predominantly nucleocytoplasmic in pachytene germ cells, 
although there appears to be some punctate staining within the nucleus as well. (C) 
Merge of (A) and (B). METT-10::GFP and DLC-1 do not colocalize; rather, nuclear 
puncta appear to be adjacent to one another. (D) Neither DLC-1 nor METT-10::GFP 
puncta extensively co-localize with DNA. 
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Figure 8. A dual mechanism ensures METT-10 nuclear accumulation. (A) 
Domain architecture of METT-10 marked with protein sequence change caused by 
mett-10(oz36) and location of the DLC-1 binding motif.  Gray shading highlights the 
conserved methyltransferase-10 domain, and purple indicates the nuclear localization 
consensus sequence. (B-G) Confocal images (0.3 microns) of wild type and mutant 
METT-10::GFP expression in gonadal sheath cells stained with antibodies against 
GFP and lamin to visualize nuclear membrane. 
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Figure 9.  Measurements of mett-10 transgenic and endogenous expression. (A) 
qRT-PCR analysis for levels of endogenous and transgenic mett-10 expression.  All 
transgenes were crossed into the mett-10(ok2204) background, which contains a large 
deletion of the N-terminal portion of the gene.  Primers corresponding to this deleted 
region were used to measure gene expression (see Methods).  These primers amplify 
the endogenous gene in a wild type genetic background, and only the transgene in the 
mett-10(ok2204); mett-10::gfp genetic background.  Expression values shown 
correspond to a calculated ratio of mett-10 to actin expression, with endogenous gene 
expression normalized to a value of 1 (see Methods). (B) IP-Westerns of wild type 
and mett-10(5A)::gfp transgenes. 
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Figure 10. A cytoplasmic version of METT-10 can partially suppress the mett-
10(ok2204) RNAi-resistance phenotype.  mett-10(ok2204)  animals carrying either 
wild type mett-10::gfp, mett-10(5A)::gfp, or mett-10(-NLS, 5A)::gfp were fed dsRNA 
directed against the germ line –expressed gene, gld-1.  F1 animals were scored for 
two phenotypes associated with gld-1 disruption: small oocytes (less severe) and 
ectopic proximal proliferation (more severe).   
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Figure 11. mett-10 mutants enhance dynein loss-of-function phenotypes of the 
dhc-1(js319) allele. (A, C-D) Most dhc-1(js319)mutant germ lines are relatively 
normal at both 20 and 25˚C, although they exhibit polyploidy (large DNA-dense 
nuclei) and univalent (unpaired chromosomes in diakinesis) at very low penetrance.  
(B, E-F) Double mutants between dhc-1(js319) and any mett-10 allele leads to 
significant enhancement of both these phenotypes, and all double mutant animals are 
sterile.  This set of phenotypes closely phenocopies loss of dlc-1 function in the germ 
line. 
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Figure 12. Schematic of dynein heavy chain-1 mutations. (A) Diagram of 
intron/exon structure of the dhc-1 locus, with encoded protein domains.  The N-
terminal tail region contains that binding sites for Dynein Intermediate Chain (DIC) 
and Dynein Light Intermediate Chain (LIC) (blue) (Tynan et al., 2000). These are 
followed by the first four ATPase domains containing consensus P-loop sequences 
(yellow), followed by the microtubule stalk and globular microtubule binding domain 
(red) (Koonce and Tikhonenko, 2000).  Locations of the nucleotide changes in dhc-
1(js121), dhc-1(or195), and dhc-1(js319) are shown. (B) Model of Dynein Heavy 
Chain with location of mutant alleles.  If we assume that the splice acceptor mutations 
lead to exon skipping, dhc-1(js121) would lead to a deletion within the linker domain, 
while dhc-1(js319) would truncate DHC-1 C-terminal to the 5th and 6th ATPase-like 
domains. 
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Chapter 4 (Discussion):  
The Pleiotropic Consequences of mett-10 Disruption 
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        “Always the beautiful answer who asks a more beautiful question.” 
                                            -e.e. cummings, 1938 
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The goal of development is to build and maintain an organism.  METT-10 is 
an interesting protein in that it plays roles in both the construction and maintenance of 
C.elegans.  In addition to an essential role in development of the embryo, vulva, and 
somatic gonad, METT-10 regulates germ cell proliferation and promotes the 
production of gametes by ensuring normal mitotic cell cycle progression and meiotic 
development.  These essential functions of METT-10 in germ cells maintain the 
gamete population in adult life and the species in general.  
 Although our initial interest in mett-10 centered on its function in proliferative 
fate specification, the studies presented here uncovered additional cellular roles in 
RNA interference, dynein function in mitosis and meiosis, cell cycle progression, and 
meiotic development.  A central question that arises from these findings is whether a 
single cellular function underlies the diversity of mett-10 phenotypes and whether 
some phenotypes are the downstream consequences of another.  Alternatively, these 
cellular functions and their associated phenotypes might be separable and 
independent.  Understanding the causal relationship between underlying cellular 
function and phenotype will enhance our understanding of the construction and 
maintenance of the organism as a functioning whole, and the imbalance that underlies 
disease. 
 
Methyltransferase activity likely underlies all cellular functions of METT-10 
METT-10 most likely functions as a methyltransferase.  It contains a full 
SAM-dependent methyltransferase fold and the human homolog binds SAM (Wu et 
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al., To be published.).  Significantly, the oj32 allele mutates a highly conserved 
glycine that forms the core of the SAM-binding pocket, and is predicted to reduce 
methyltransferase activity.  The mett-10(oj32) mutant exhibits defects in proliferative 
fate specification, RNA interference, cell cycle progression, and promotion of dynein 
function, suggesting that methyltransferase activity underlies all METT-10 cellular 
functions (Figure 1).  We do not know what METT-10 methylates, or the functional 
consequence of methylation, but it is likely that METT-10 has multiple targets.  This 
is supported by the phenotype of the tumorous mett-10(oz36) mutant, which 
preferentially affects proliferative fate specification under lower temperature 
conditions. 
 
Joint functions of METT-10 and dynein in the C. elegans germ line 
 DLC-1 and METT-10 cooperatively inhibit proliferative cell fate (Figure 1). 
DLC-1 interacts physically with METT-10, promotes mett-10 RNA levels, and, in the 
context of the motor complex, promotes METT-10 nuclear localization. Moreover, 
the role of dynein in regulation of proliferative fate is not limited to regulation of 
METT-10 alone, as genetic disruption of either dlc-1 or dhc-1 can enhance the 
tumorous phenotype of the mett-10(oz36) mutant that lacks the DLC-1-binding motif. 
In addition to a joint function in proliferative fate specification, METT-10 
promotes other dynein-dependent processes (Figure 1). Loss of mett-10 function 
enhances the mitotic and meiotic defects of a weak dynein heavy chain loss-of-
function allele, leading to polyploidy and unpaired diakinetic chromosomes.  
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Expression of a METT-10 protein that is unable to bind DLC-1 acts as a dominant 
negative and causes germ cell polyploidy, suggesting that it may disrupt a DLC-1-
containing complex. Finally, the mett-10(oj32) loss-of-function allele has a defect in 
centrosome flattening, a dynein-dependent process, during the first embryonic 
division (O'Connell et al., 1998). 
The genetic interactions between mett-10 and dlc-1 in proliferative fate 
specification, mitotic cell division, and meiosis suggest that these different cellular 
functions may have a common underlying mechanism.  However, the experiments 
presented here delineate a role for DLC-1 in promoting METT-10 activity during 
proliferative fate specification, and a role for METT-10 in promoting DLC-1 activity 
during cell division and meiotic pairing and/or recombination.  The most 
parsimonious interpretation of these findings is that METT-10 promotes DLC-1 
activity, which, in turn, promotes METT-10 function in a positive feedback loop 
(Figure 2).    
How could METT-10 affect DLC-1 function? DLC-1 is an LC8-type dynein 
light chain, which exists as a dimer when associated with the dynein motor complex 
(Vale, 2003). Two models have been proposed for the role of the LC8 dynein light 
chain with respect to the dynein motor complex. One model suggests that LC8 dimers 
act as dimerization hubs, binding to regions of intrinsic disorder in a diverse set of 
proteins, leading to increased structural organization and dimerization (Wang et al., 
2004; Barbar, 2008). This model proposes that LC8 promotes normal dynein function 
by promoting dimerization of the dynein intermediate chain (Barbar, 2008; King, 
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2008). Indeed, since METT-10 can simultaneously bind to itself and to DLC-1, it is 
possible that DLC-1 promotes METT-10 dimerization in vivo. A second model 
proposes that DLC-1/LC8 functions as a cargo adaptor molecule, enabling the 
association of the dynein motor complex with a wide spectrum of proteins (Karki and 
Holzbaur, 1999; Navarro et al., 2004; Lee et al., 2006).  The unifying theme of both 
models is that DLC-1 carries out multiple cellular functions by binding to and 
regulating the function of a diverse set of target proteins.  It is possible that METT-10 
methylates targets of the dynein motor complex, and that this methylation event 
promotes their association with DLC-1 or the motor complex.  Alternatively, METT-
10 and DLC-1 could coordinately regulate target proteins by coupling multiple modes 
of regulation, such as post-translational modification and subcellular localization.  In 
both cases, association with dynein would enhance METT-10 function, but may not 
be essential. 
 
The relationship of RNA interference to other METT-10 cellular functions 
Small RNAs play broad roles in development, and given their roles in 
regulation of gene expression and chromatin structure, it is no surprise that defects in 
RNA-mediated silencing lead to widespread alterations in development (Zamore and 
Haley, 2005) .  Indeed, the microRNA pathway was first characterized for its role in 
developmental timing, and many RNAi genes, particularly the Argonaute family of 
proteins, play essential and conserved roles in germ line maintenance and function 
(Lee et al., 1993; Deng and Lin, 2002; Yigit et al., 2006).  Moreover, multiple RNAi 
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mutants exhibit cell division defects that are thought to arise from function of RNA-
mediated silencing in regulation of chromatin structure (Zamore and Haley, 2005; 
Yigit et al., 2006).  Thus, while the role of METT-10 in RNAi is unlikely to 
completely account for its function in proliferative fate specification (see Discussion, 
Chapter 2), it probably contributes to the gross morphological defects observed in 
mett-10 mutants (Figure 1).   
 Could there be any functional overlap between the roles of METT-10 in RNAi 
and in dynein function? While we did not detect an RNAi defect for multiple alleles 
of dynein heavy chain-1 (data not shown), several emerging lines of evidence point to 
a functional connection between RNAi-related processes and the cytoskeleton.  In 
Drosophila germ cells, defects in the piRNA pathway lead to the formation of large 
aggregates of dynein heavy chain in the cytoplasm (Navarro et al., 2009).  Moreover, 
two different RNAi screens have identified roles for cytoskeletal factors in promoting 
RNA-mediated silencing pathways.  For example, a group of genes that act in the 
dynein–dependent pathway mediating asymmetric division and centrosome flattening  
(lin-5 and gpr-1/2) can promote transgene silencing (Kim et al., 2005), while roles for 
tubulin, dynactin, and various dynein subunits are proposed to mediate lin-14 
silencing via the microRNA pathway (Parry et al., 2007).   Thus, it is possible that the 
dual roles of METT-10 in dynein function and RNAi are not coincidental, and further 
investigation may illuminate a mechanism underlying the functional connections 
between the cytoskeleton and RNA-mediated silencing.  
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A complete picture?  
 An organism is less the sum of its component parts than it is the sum of their 
connections.  Homeostasis and survival require not just that individual organs or 
tissues are connected, but that all cellular pathways are connected to each other in a 
network.  Genome-wide studies of gene expression and physical association of 
proteins can drive our ideas of how such vast networks are organized, but in depth 
studies of genes like mett-10 whose roles span seemingly disparate cellular functions 
may eventually make concrete contributions to our understanding of the complex 
interactions between cellular machinery, gene regulatory mechanisms, and the 
phenotypic consequences of their disruption. 
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Figure 1.  A model for the pleiotropic consequences of mett-10 disruption.  
METT-10 plays roles in multiple cellular processes, but the relationship between 
these processes (yellow), their underlying mechanisms (orange), and the phenotypic 
consequences of their disruption (green) are not well understood.  It is likely that 
METT-10 methyltransferase activity (red) is essential for all METT-10 functions, that 
METT-10 has multiple targets, that there is significant interplay between these 
functions, and that the phenotypic effects of mett-10 disruption are the downstream 
consequence of multiple underlying cellular defects.  In the diagram, line thickness 
represents strength of experimental evidence supporting the functional connection, 
with dotted lines have the least supporting experimental evidence. 
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Figure 2.  A genetic model for joint functions of METT-10 and DLC-1.  METT-
10 and DLC-1 both function in glp-1-dependent inhibition of proliferative fate, the 
avoidance of polyploidy, centrosome flattening (O'Connell et al., 1998), and in 
meiotic pairing and/or recombination.  In the inhibition of proliferative fate, DLC-1 
promotes METT-10 levels and localization.  However, dlc-1 activity is essential for 
other functions (red), while METT-10 function is not.  The most parsimonious 
explanation is that METT-10 normally promotes DLC-1 function, and DLC-1 in turn 
promotes METT-10 activity in a positive feedback loop. 
 
 
